Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Peptic Ulcer

  Free Subscription

Articles published in Helicobacter

Retrieve available abstracts of 358 articles:
HTML format

Single Articles

    July 2021
  1. ZHAO J, Zou Y, Li K, Huang X, et al
    Doxycycline and minocycline in Helicobacter pylori treatment: A systematic review and meta-analysis.
    Helicobacter. 2021 Jul 28:e12839. doi: 10.1111/hel.12839.
    PubMed     Abstract available

  2. ZOU PY, Hu J, Zhao JT, Zhao Z, et al
    10-Day and 14-day high-dose dual therapy for the treatment of Helicobacter pylori: A propensity score matching analysis.
    Helicobacter. 2021 Jul 28:e12833. doi: 10.1111/hel.12833.
    PubMed     Abstract available

  3. KOWADA A, Asaka M
    Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis.
    Helicobacter. 2021 Jul 18:e12837. doi: 10.1111/hel.12837.
    PubMed     Abstract available

  4. GUNATHILAKE M, Lee J, Choi IJ, Kim YI, et al
    Association between bacteria other than Helicobacter pylori and the risk of gastric cancer.
    Helicobacter. 2021 Jul 15:e12836. doi: 10.1111/hel.12836.
    PubMed     Abstract available

  5. OUYANG Y, Zhu Z, Huang L, Zeng C, et al
    Research Trends on Clinical Helicobacter pylori Eradication: A Bibliometric Analysis from 1983 to 2020.
    Helicobacter. 2021 Jul 13:e12835. doi: 10.1111/hel.12835.
    PubMed     Abstract available

  6. GUNARATNE AW, Hamblin H, Clancy A, Magat AJMC, et al
    Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections-Exploratory study.
    Helicobacter. 2021 Jul 10:e12830. doi: 10.1111/hel.12830.
    PubMed     Abstract available

    cagA+ Helicobacter pylori infection and N-nitrosodimethylamine and cholangiocarcinoma.
    Helicobacter. 2021 Jul 8:e12834. doi: 10.1111/hel.12834.

  8. MA H, Zhao XH, Zhang LL, Wu LM, et al
    Application of WeChat platform in the management of patients infected with Helicobacter pylori.
    Helicobacter. 2021 Jul 7:e12832. doi: 10.1111/hel.12832.
    PubMed     Abstract available

  9. HE Y, Ning J, Li B, Guo H, et al
    IL-9 contributes to the host immune response against Helicobacter pylori and helps limit infection in a Mouse Model.
    Helicobacter. 2021 Jul 7:e12827. doi: 10.1111/hel.12827.
    PubMed     Abstract available

    June 2021
  10. TSAI CF, Chen MH, Wang YP, Liu PY, et al
    Increased risk of short-term depressive disorder after Helicobacter pylori eradication: A population-based nested cohort study.
    Helicobacter. 2021 Jun 11:e12824. doi: 10.1111/hel.12824.
    PubMed     Abstract available

  11. QIU E, Jin S, Xiao Z, Chen Q, et al
    CRISPR-based detection of Helicobacter pylori in stool samples.
    Helicobacter. 2021 Jun 11:e12828. doi: 10.1111/hel.12828.
    PubMed     Abstract available

  12. KOTILEA K, Cadranel S, Salame A, Nguyen J, et al
    Efficacy and safety of bismuth-based quadruple therapy for Helicobacter pylori eradication in children.
    Helicobacter. 2021 Jun 7:e12825. doi: 10.1111/hel.12825.
    PubMed     Abstract available

    May 2021
  13. MONZANI A, Lionetti P, Rabbone I, Lionetti E, et al
    The best is the enemy of the good: Time for a biopsy-sparing approach for Helicobacter pylori diagnosis and treatment in children in the COVID-19 era?
    Helicobacter. 2021 May 28:e12826. doi: 10.1111/hel.12826.

  14. DANGTAKOT R, Intuyod K, Chamgramol Y, Pairojkul C, et al
    CagA(+) Helicobacter pylori infection and N-nitrosodimethylamine administration induce cholangiocarcinoma development in hamsters.
    Helicobacter. 2021 May 24:e12817. doi: 10.1111/hel.12817.
    PubMed     Abstract available

  15. LI C, Shi Y, Suo B, Tian X, et al
    PPI-amoxicillin dual therapy four times daily is superior to guidelines recommended regimens in the Helicobacter pylori eradication therapy within Asia: A systematic review and meta-analysis.
    Helicobacter. 2021 May 17:e12816. doi: 10.1111/hel.12816.
    PubMed     Abstract available

  16. TSUKADAIRA T, Hayashi S, Ota H, Kobayashi N, et al
    Acute gastric mucosal lesions caused by acute infection of non-Helicobacter pylori Helicobacter: a case report.
    Helicobacter. 2021 May 11:e12814. doi: 10.1111/hel.12814.
    PubMed     Abstract available

  17. ZHANG Z, Chen S, Fan M, Ruan G, et al
    Helicobacter pylori induces gastric cancer via down-regulating miR-375 to inhibit dendritic cell maturation.
    Helicobacter. 2021 May 3:e12813. doi: 10.1111/hel.12813.
    PubMed     Abstract available

    April 2021
  18. HERNANDEZ C, Toledo-Stuardo K, Garcia-Gonzalez P, Garrido-Tapia M, et al
    Heat-killed Helicobacter pylori upregulates NKG2D ligands expression on gastric adenocarcinoma cells via Toll-like receptor 4.
    Helicobacter. 2021 Apr 29:e12812. doi: 10.1111/hel.12812.
    PubMed     Abstract available

  19. TSUKADAIRA T, Hayashi S, Ota H, Kobayashi N, et al
    Prevalence, clinical features, and esophagogastroduodenoscopy (EGD) findings of non-Helicobacter pylori Helicobacter infection: A study of 50 cases at a single facility in Japan.
    Helicobacter. 2021 Apr 27:e12811. doi: 10.1111/hel.12811.
    PubMed     Abstract available

  20. WANG X, Shu X, Li Q, Li Y, et al
    Prevalence and risk factors of Helicobacter pylori infection in Wuwei, a high-risk area for gastric cancer in northwest China: An all-ages population-based cross-sectional study.
    Helicobacter. 2021 Apr 27:e12810. doi: 10.1111/hel.12810.
    PubMed     Abstract available

  21. ZHOU Y, Ye Z, Wang Y, Huang Z, et al
    Long-term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children.
    Helicobacter. 2021 Apr 25:e12809. doi: 10.1111/hel.12809.
    PubMed     Abstract available

  22. LI SY, Li J, Dong XH, Teng GG, et al
    The effect of previous eradication failure on antibiotic resistance of Helicobacter pylori: A retrospective study over 8 years in Beijing.
    Helicobacter. 2021 Apr 16:e12804. doi: 10.1111/hel.12804.
    PubMed     Abstract available

  23. XIE W, Zhao W, Zou Z, Kong L, et al
    Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice.
    Helicobacter. 2021 Apr 12:e12807. doi: 10.1111/hel.12807.
    PubMed     Abstract available

  24. DO AD, Chang CC, Su CH, Hsu YM, et al
    Lactobacillus rhamnosus JB3 inhibits Helicobacter pylori infection through multiple molecular actions.
    Helicobacter. 2021 Apr 11:e12806. doi: 10.1111/hel.12806.
    PubMed     Abstract available

  25. TURNER KO, Lindberg GM, Genta RM
    Gastric granulomas and Helicobacter pylori: An incidental relationship.
    Helicobacter. 2021 Apr 11:e12805. doi: 10.1111/hel.12805.
    PubMed     Abstract available

  26. YORGUC E, Gulerman HF, Kalkan IH, Guven B, et al
    Comparison of clinical outcomes and FOXP3, IL-17A responses in Helicobacter pylori infection in children versus adults.
    Helicobacter. 2021 Apr 5:e12795. doi: 10.1111/hel.12795.
    PubMed     Abstract available

  27. KUBOTA-AIZAWA S, Matsubara Y, Kanemoto H, Mimuro H, et al
    Transmission of Helicobacter pylori between a human and two dogs: A case report.
    Helicobacter. 2021 Apr 5:e12798. doi: 10.1111/hel.12798.
    PubMed     Abstract available

    March 2021
  28. LI Y, Li X, Tan Z
    An overview of traditional Chinese medicine therapy for Helicobacter pylori-related gastritis.
    Helicobacter. 2021 Mar 25:e12799. doi: 10.1111/hel.12799.
    PubMed     Abstract available

  29. CHIANG TH, Chen CC, Tseng PH, Liou JM, et al
    Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study.
    Helicobacter. 2021 Mar 19:e12801. doi: 10.1111/hel.12801.
    PubMed     Abstract available

  30. HEFFLEY JD, Zubarik R
    A standardized protocol improves testing rates for Helicobacter Pylori among inpatients with peptic ulcer disease.
    Helicobacter. 2021 Mar 15:e12800. doi: 10.1111/hel.12800.
    PubMed     Abstract available

  31. MARUBASHI K, Takakusagi S, Yokoyama Y, Kizawa K, et al
    Changes of (18) F-fluoro-2-deoxyglucose position-emission tomography findings by the eradication of Helicobacter pylori in the stomach.
    Helicobacter. 2021 Mar 8:e12797. doi: 10.1111/hel.12797.
    PubMed     Abstract available

  32. ZHAO JB, Yuan L, Yu XC, Shao QQ, et al
    Whole family-based Helicobacter pylori eradication is a superior strategy to single-infected patient treatment approach: A systematic review and meta-analysis.
    Helicobacter. 2021 Mar 6:e12793. doi: 10.1111/hel.12793.
    PubMed     Abstract available

  33. JAIN U, Saxena K, Chauhan N
    Helicobacter pylori induced reactive oxygen Species: A new and developing platform for detection.
    Helicobacter. 2021 Mar 5:e12796. doi: 10.1111/hel.12796.
    PubMed     Abstract available

  34. TENG TZJ, Sudharsan M, Yau JWK, Tan W, et al
    Helicobacter pylori knowledge and perception among multi-ethnic Asians.
    Helicobacter. 2021 Mar 3:e12794. doi: 10.1111/hel.12794.
    PubMed     Abstract available

  35. KIM YJ, Chung WC, Kim DB
    Efficacy of bismuth added to standard triple therapy as the first-line eradication regimen for Helicobacter pylori infection.
    Helicobacter. 2021 Mar 1:e12792. doi: 10.1111/hel.12792.
    PubMed     Abstract available

    February 2021
  36. HUANG Y, Ding Y, Xu H, Shen C, et al
    Effects of sodium butyrate supplementation on inflammation, gut microbiota, and short-chain fatty acids in Helicobacter pylori-infected mice.
    Helicobacter. 2021 Feb 20:e12785. doi: 10.1111/hel.12785.
    PubMed     Abstract available

  37. XIE M, Li Q, Zhang B, Zhang Q, et al
    Preliminary single-center experience of Helicobacter pylori eradication among the liver transplant recipients.
    Helicobacter. 2021 Feb 18:e12791. doi: 10.1111/hel.12791.
    PubMed     Abstract available

  38. GANTUYA B, El Serag HB, Saruuljavkhlan B, Azzaya D, et al
    Advantage of 16S rRNA amplicon sequencing in Helicobacter pylori diagnosis.
    Helicobacter. 2021 Feb 17:e12790. doi: 10.1111/hel.12790.
    PubMed     Abstract available

  39. LEE BE, Kim JS, Kim BW, Kim JH, et al
    Consistency of Helicobacter pylori eradication rates of first-line concomitant and sequential therapies in Korea: A nationwide multicenter retrospective study for the last 10 years.
    Helicobacter. 2021 Feb 17:e12780. doi: 10.1111/hel.12780.
    PubMed     Abstract available

  40. WU ZF, Zou K, Xiang CJ, Jin ZJ, et al
    Helicobacter pylori infection is associated with the co-occurrence of bacteria in the oral cavity and the gastric mucosa.
    Helicobacter. 2021 Feb 17:e12786. doi: 10.1111/hel.12786.
    PubMed     Abstract available

  41. YANG KY, Kao CY, Su MS, Wang S, et al
    Glycosyltransferase Jhp0106 (PseE) contributes to flagellin maturation in Helicobacter pylori.
    Helicobacter. 2021 Feb 15:e12787. doi: 10.1111/hel.12787.
    PubMed     Abstract available

  42. LACOUT C, Savey L, Bourguiba R, Giurgea I, et al
    "Helicobacter pylori in familial mediterranean fever: A series of 120 patients from literature and from france".
    Helicobacter. 2021 Feb 15:e12789. doi: 10.1111/hel.12789.
    PubMed     Abstract available

  43. ETO H, Suzuki S, Kusano C, Ikehara H, et al
    Impact of body size on first-line Helicobacter pylori eradication success using vonoprazan and amoxicillin dual therapy.
    Helicobacter. 2021 Feb 12:e12788. doi: 10.1111/hel.12788.
    PubMed     Abstract available

  44. HU Y, Ouyang Y, Zhu Y, Lu NH, et al
    Reverse hybrid therapy for Helicobacter pylori eradication: A systematic review and meta-analysis.
    Helicobacter. 2021 Feb 3:e12784. doi: 10.1111/hel.12784.
    PubMed     Abstract available

    January 2021
  45. PARK Y, Kim TJ, Lee H, Yoo H, et al
    Eradication of Helicobacter pylori infection decreases risk for dyslipidemia: A cohort study.
    Helicobacter. 2021 Jan 28:e12783. doi: 10.1111/hel.12783.
    PubMed     Abstract available

  46. DOMANOVICH-ASOR T, Craddock HA, Motro Y, Khalfin B, et al
    Unraveling antimicrobial resistance in Helicobacter pylori: Global resistome meets global phylogeny.
    Helicobacter. 2021 Jan 25:e12782. doi: 10.1111/hel.12782.
    PubMed     Abstract available

  47. SONG X, Cai C, Jin Q, Chen X, et al
    The efficacy of Helicobacter pylori eradication in diabetics and its effect on glycemic control: A systematic review and meta-analysis.
    Helicobacter. 2021 Jan 19:e12781. doi: 10.1111/hel.12781.
    PubMed     Abstract available

  48. WEN Y, Huang H, Tang T, Yang H, et al
    AI-2 represses CagA expression and bacterial adhesion, attenuating the Helicobacter pylori-induced inflammatory response of gastric epithelial cells.
    Helicobacter. 2021 Jan 5:e12778. doi: 10.1111/hel.12778.
    PubMed     Abstract available

  49. MUNOZ AB, Trespalacios-Rangel AA, Vale FF
    An American lineage of Helicobacter pylori prophages found in Colombia.
    Helicobacter. 2021 Jan 5:e12779. doi: 10.1111/hel.12779.
    PubMed     Abstract available

  50. JUNG K, Kim DH, Seo HI, Gong EJ, et al
    Efficacy of eradication therapy in Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: A meta-analysis.
    Helicobacter. 2021 Jan 5:e12774. doi: 10.1111/hel.12774.
    PubMed     Abstract available

    December 2020
  51. XUE Q, Li X, Li Y, Xu J, et al
    Dialogue between gastrointestinal tract and skin: New insights into the Helicobacter pylori and atopic dermatitis.
    Helicobacter. 2020 Dec 23:e12771. doi: 10.1111/hel.12771.
    PubMed     Abstract available

  52. QARIA MA, Qumar S, Sepe LP, Ahmed N, et al
    Cholesterol glucosylation-based survival strategy in Helicobacter pylori.
    Helicobacter. 2020 Dec 23:e12777. doi: 10.1111/hel.12777.
    PubMed     Abstract available

  53. KAKIUCHI T, Matsuo M, Endo H, Sakata Y, et al
    Gastrointestinal adverse reactions reduce the success rate of Helicobacter pylori eradication therapy: A multicenter prospective cohort study.
    Helicobacter. 2020 Dec 23:e12776. doi: 10.1111/hel.12776.
    PubMed     Abstract available

  54. JUKIC I, Vukovic J, Rusic D, Bozic J, et al
    Adherence to Maastricht V/Florence consensus report for the management of Helicobacter pylori infection among primary care physicians and medical students in Croatia: A cross-sectional study.
    Helicobacter. 2020 Dec 23:e12775. doi: 10.1111/hel.12775.
    PubMed     Abstract available

  55. BANGA NDZOUBOUKOU JL, Lei Q, Ullah N, Zhang Y, et al
    Helicobacter pylori adhesins: HpaA a potential antigen in experimental vaccines for H. pylori.
    Helicobacter. 2020 Dec 1:e12758. doi: 10.1111/hel.12758.
    PubMed     Abstract available

    November 2020
  56. CEN Q, Gao T, Ren Y, Lu X, et al
    Immune evaluation of a Saccharomyces cerevisiae-based oral vaccine against Helicobacter pylori in mice.
    Helicobacter. 2020 Nov 20:e12772. doi: 10.1111/hel.12772.
    PubMed     Abstract available

  57. GRAHAM DY, Megraud F
    Classification system for Helicobacter pylori therapies: Compared and contrasted to traditional infectious disease therapy.
    Helicobacter. 2020 Nov 18:e12773. doi: 10.1111/hel.12773.

  58. SINGH H, Chung H, Awan I, Mone A, et al
    Designing strategies for eradication of Helicobacter pylori based on prevalence patterns of infection and antibiotic resistance in a low-income, medically underserved community in the United States.
    Helicobacter. 2020 Nov 9:e12769. doi: 10.1111/hel.12769.
    PubMed     Abstract available

    October 2020
  59. PIH GY, Choi KD, Gong EJ, Na HK, et al
    Modified bismuth quadruple therapy with low-dose metronidazole as first-line therapy for Helicobacter pylori infection.
    Helicobacter. 2020 Oct 28:e12759. doi: 10.1111/hel.12759.
    PubMed     Abstract available

  60. MEGRAUD F, Alix C, Charron P, Benejat L, et al
    Survey of the antimicrobial resistance of Helicobacter pylori in France in 2018 and evolution during the previous 5 years.
    Helicobacter. 2020 Oct 22:e12767. doi: 10.1111/hel.12767.
    PubMed     Abstract available

  61. KE H, Li J, Lu B, Yang C, et al
    The appropriate cutoff gastric pH value for Helicobacter pylori eradication with bismuth-based quadruple therapy.
    Helicobacter. 2020 Oct 21:e12768. doi: 10.1111/hel.12768.
    PubMed     Abstract available

  62. QUMAR S, Nguyen TH, Nahar S, Sarker N, et al
    A comparative whole genome analysis of Helicobacter pylori from a human dense South Asian setting.
    Helicobacter. 2020 Oct 18:e12766. doi: 10.1111/hel.12766.
    PubMed     Abstract available

  63. MIYATA E, Kudo T, Ikuse T, Tokita K, et al
    Eradication therapy for Helicobacter pylori infection based on the antimicrobial susceptibility test in children: A single-center study over 12 years.
    Helicobacter. 2020 Oct 18:e12764. doi: 10.1111/hel.12764.
    PubMed     Abstract available

  64. HOFREUTER D, Behrendt J, Franz A, Meyer J, et al
    Antimicrobial resistance of Helicobacter pylori in an eastern German region.
    Helicobacter. 2020 Oct 17:e12765. doi: 10.1111/hel.12765.
    PubMed     Abstract available

  65. SONG Z, Zhou L, Xue Y, Suo B, et al
    A comparative study of 14-day dual therapy (esomeprazole and amoxicillin four times daily) and triple plus bismuth therapy for first-line Helicobacter pylori infection eradication: A randomized trial.
    Helicobacter. 2020 Oct 11:e12762. doi: 10.1111/hel.12762.
    PubMed     Abstract available

  66. WANG B, Yu M, Zhang R, Chen S, et al
    A meta-analysis of the association between Helicobacter pylori infection and risk of atherosclerotic cardiovascular disease.
    Helicobacter. 2020 Oct 7:e12761. doi: 10.1111/hel.12761.
    PubMed     Abstract available

  67. ALVAREZ CS, Florio AA, Butt J, Rivera-Andrade A, et al
    Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala.
    Helicobacter. 2020 Oct 2:e12756. doi: 10.1111/hel.12756.
    PubMed     Abstract available

  68. HUANG JW, Xie C, Niu Z, He LJ, et al
    The relation between Helicobacter pylori immunoglobulin G seropositivity and leukocyte telomere length in US adults from NHANES 1999-2000.
    Helicobacter. 2020 Oct 1:e12760. doi: 10.1111/hel.12760.
    PubMed     Abstract available

    September 2020
  69. ARSLAN M, Balamtekin N, Gunal A
    Efficacy of a novel sequential treatment regimen containing bismuth for Helicobacter pylori eradication in Turkish children.
    Helicobacter. 2020 Sep 17:e12757. doi: 10.1111/hel.12757.
    PubMed     Abstract available

  70. ZHOU JJ, Shi X, Zheng SP, Tang D, et al
    Efficacy of bismuth-based quadruple therapy for eradication of Helicobacter pylori infection based on previous antibiotic exposure: A large-scale prospective, single-center clinical trial in China.
    Helicobacter. 2020 Sep 11:e12755. doi: 10.1111/hel.12755.
    PubMed     Abstract available

  71. SUAREZ-JARAMILLO A, Baldeon ME, Prado B, Fornasini M, et al
    Duodenal microbiome in patients with or without Helicobacter pylori infection.
    Helicobacter. 2020 Sep 8:e12753. doi: 10.1111/hel.12753.
    PubMed     Abstract available

  72. TAO ZH, Han JX, Fang JY
    Helicobacter pylori infection and eradication: Exploring their impacts on the gastrointestinal microbiota.
    Helicobacter. 2020 Sep 2:e12754. doi: 10.1111/hel.12754.
    PubMed     Abstract available

  73. GODBOLE G, Megraud F, Bessede E
    Review: Diagnosis of Helicobacter pylori infection.
    Helicobacter. 2020;25 Suppl 1:e12735.
    PubMed     Abstract available

  74. SEO JH, Bortolin K, Jones NL
    Review: Helicobacter pylori infection in children.
    Helicobacter. 2020;25 Suppl 1:e12742.
    PubMed     Abstract available

  75. DENIC M, Touati E, De Reuse H
    Review: Pathogenesis of Helicobacter pylori infection.
    Helicobacter. 2020;25 Suppl 1:e12736.
    PubMed     Abstract available

  76. O'CONNOR A, Furuta T, Gisbert JP, O'Morain C, et al
    Review - Treatment of Helicobacter pylori infection 2020.
    Helicobacter. 2020;25 Suppl 1:e12743.
    PubMed     Abstract available

  77. SCHULZ C, Kupcinskas J
    Review - Helicobacter pylori and non-malignant upper gastro-intestinal diseases.
    Helicobacter. 2020;25 Suppl 1:e12738.
    PubMed     Abstract available

  78. MEZMALE L, Coelho LG, Bordin D, Leja M, et al
    Review: Epidemiology of Helicobacter pylori.
    Helicobacter. 2020;25 Suppl 1:e12734.
    PubMed     Abstract available

  79. PELLICANO R, Ianiro G, Fagoonee S, Settanni CR, et al
    Review: Extragastric diseases and Helicobacter pylori.
    Helicobacter. 2020;25 Suppl 1:e12741.
    PubMed     Abstract available

    August 2020
  80. YUSIBOVA M, Hasman H, Clausen PTLC, Imkamp F, et al
    CRHP Finder, a webtool for the detection of clarithromycin resistance in Helicobacter pylori from whole-genome sequencing data.
    Helicobacter. 2020 Aug 26:e12752. doi: 10.1111/hel.12752.
    PubMed     Abstract available

  81. ESLICK GD, Tilden D, Arora N, Torres M, et al
    Clinical and economic impact of "triple therapy" for Helicobacter pylori eradication on peptic ulcer disease in Australia.
    Helicobacter. 2020 Aug 20:e12751. doi: 10.1111/hel.12751.
    PubMed     Abstract available

  82. SALEHI N, Attaran B, Zare-Mirakabad F, Ghadiri B, et al
    The outward shift of clarithromycin binding to the ribosome in mutant Helicobacter pylori strains.
    Helicobacter. 2020 Aug 14:e12731. doi: 10.1111/hel.12731.
    PubMed     Abstract available

  83. NAKAMURA M, Overby A, Michimae H, Matsui H, et al
    PCR analysis and specific immunohistochemistry revealing a high prevalence of non-Helicobacter pylori Helicobacters in Helicobacter pylori-negative gastric disease patients in Japan: High susceptibility to an Hp eradication regimen.
    Helicobacter. 2020 Aug 13:e12700. doi: 10.1111/hel.12700.
    PubMed     Abstract available

  84. GUDRA D, Pupola D, Skenders G, Leja M, et al
    Lack of significant differences between gastrointestinal tract microbial population structure of Helicobacter pylori-infected subjects before and 2 years after a single eradication event.
    Helicobacter. 2020 Aug 9:e12748. doi: 10.1111/hel.12748.
    PubMed     Abstract available

  85. ZHANG Y, Dong Q, Tian L, Zhang S, et al
    Risk factors for recurrence of Helicobacter pylori infection after successful eradication in Chinese children: A prospective, nested case-control study.
    Helicobacter. 2020 Aug 7:e12749. doi: 10.1111/hel.12749.
    PubMed     Abstract available

  86. GONG EJ, Ahn JY, Jung DK, Lee SM, et al
    Isolation of Helicobacter pylori using leftover tissue in the rapid urease test kit.
    Helicobacter. 2020 Aug 3:e12733. doi: 10.1111/hel.12733.
    PubMed     Abstract available

    July 2020
  87. KAWAHARA Y, Hirashita Y, Tamura C, Kudo Y, et al
    Helicobacter pylori infection modulates endogenous hydrogen sulfide production in gastric cancer AGS cells.
    Helicobacter. 2020 Jul 26:e12732. doi: 10.1111/hel.12732.
    PubMed     Abstract available

  88. HWONG-RUEY LEOW A, Chang JV, Goh KL
    Searching for an optimal therapy for H pylori eradication: High-dose proton-pump inhibitor dual therapy with amoxicillin vs. standard triple therapy for 14 days.
    Helicobacter. 2020 Jul 26:e12723. doi: 10.1111/hel.12723.
    PubMed     Abstract available

  89. SHOLEH M, Maleki F, Krutova M, Bavari S, et al
    The increasing antimicrobial resistance of Helicobacter pylori in Iran: A systematic review and meta-analysis.
    Helicobacter. 2020 Jul 23:e12730. doi: 10.1111/hel.12730.
    PubMed     Abstract available

  90. KHIDDI F, Abdellahi MVM, Horma MA, Billoet A, et al
    Characteristics of Helicobacter pylori strains isolated from Mauritanian patients.
    Helicobacter. 2020 Jul 19:e12726. doi: 10.1111/hel.12726.
    PubMed     Abstract available

  91. PUNDAK OY, Topf Olivestone C, Hofi L, Kori M, et al
    Lack of association between Helicobacter pylori infection and childhood overweight/obesity.
    Helicobacter. 2020 Jul 19:e12728. doi: 10.1111/hel.12728.
    PubMed     Abstract available

  92. LI M, Sun Y, Yang J, de Martel C, et al
    Time trends and other sources of variation in Helicobacter pylori infection in mainland China: A systematic review and meta-analysis.
    Helicobacter. 2020 Jul 19:e12729. doi: 10.1111/hel.12729.
    PubMed     Abstract available

  93. WINDHAM IH, Merrell DS
    Analysis of fitness costs associated with metronidazole and amoxicillin resistance in Helicobacter pylori.
    Helicobacter. 2020 Jul 16:e12724. doi: 10.1111/hel.12724.
    PubMed     Abstract available

  94. PAL S, Sarker N, Qaria M, Tandon K, et al
    Design of an inhibitor of Helicobacter pylori cholesteryl-alpha-glucoside transferase critical for bacterial colonization.
    Helicobacter. 2020 Jul 15:e12720. doi: 10.1111/hel.12720.
    PubMed     Abstract available

  95. HEYDARI S, Siavoshi F, Jazayeri MH, Sarrafnejad A, et al
    Helicobacter pylori release from yeast as a vesicle-encased or free bacterium.
    Helicobacter. 2020 Jul 14:e12725. doi: 10.1111/hel.12725.
    PubMed     Abstract available

  96. NYSSEN OP, Perez-Aisa A, Rodrigo L, Castro M, et al
    Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg).
    Helicobacter. 2020 Jul 13:e12722. doi: 10.1111/hel.12722.
    PubMed     Abstract available

    June 2020
  97. HIRATA Y, Yamada A, Niikura R, Shichijo S, et al
    Efficacy and safety of a new rifabutin-based triple therapy with vonoprazan for refractory Helicobacter pylori infection: A prospective single-arm study.
    Helicobacter. 2020 Jun 29:e12719. doi: 10.1111/hel.12719.
    PubMed     Abstract available

  98. DEMIR AM, Berberoglu Ates B, Hizal G, Yaman A, et al
    Autoimmune atrophic gastritis: The role of Helicobacter pylori infection in children.
    Helicobacter. 2020 Jun 26:e12716. doi: 10.1111/hel.12716.
    PubMed     Abstract available

  99. GOKISIK MT, Uyar S
    The role of Helicobacter pylori in vitamin-B12 deficiency due to metformin use.
    Helicobacter. 2020 Jun 19:e12718. doi: 10.1111/hel.12718.
    PubMed     Abstract available

  100. CAI Y, Wang C, Chen Z, Xu Z, et al
    Transporters HP0939, HP0497, and HP0471 participate in intrinsic multidrug resistance and biofilm formation in Helicobacter pylori by enhancing drug efflux.
    Helicobacter. 2020 Jun 16:e12715. doi: 10.1111/hel.12715.
    PubMed     Abstract available

  101. ZOU Y, Qian X, Liu X, Song Y, et al
    The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta-analysis.
    Helicobacter. 2020 Jun 12:e12714. doi: 10.1111/hel.12714.
    PubMed     Abstract available

  102. YE Q, Shao X, Shen R, Chen D, et al
    Changes in the human gut microbiota composition caused by Helicobacter pylori eradication therapy: A systematic review and meta-analysis.
    Helicobacter. 2020 Jun 9:e12713. doi: 10.1111/hel.12713.
    PubMed     Abstract available

    May 2020
  103. WU Y, Su T, Zhou X, Lu N, et al
    Awareness and attitudes regarding Helicobacter pylori infection in Chinese physicians and public population: A national cross-sectional survey.
    Helicobacter. 2020 May 31:e12705. doi: 10.1111/hel.12705.
    PubMed     Abstract available

  104. JAIN U, Gupta S, Soni S, Khurana MP, et al
    Triple-nanostructuring-based noninvasive electro-immune sensing of CagA toxin for Helicobacter pylori detection.
    Helicobacter. 2020 May 29:e12706. doi: 10.1111/hel.12706.
    PubMed     Abstract available

  105. SEO KI, Heo JJ, Kim SE, Park SJ, et al
    Sex differences between Helicobacter pylori infection and cholesterol levels in an adult health checkup program.
    Helicobacter. 2020 May 26:e12704. doi: 10.1111/hel.12704.
    PubMed     Abstract available

  106. TANG X, Shen Y, Hu R, Yang T, et al
    Re-assessment of the disk diffusion technique for routine antimicrobial susceptibility testing for Helicobacter pylori.
    Helicobacter. 2020 May 26:e12703. doi: 10.1111/hel.12703.
    PubMed     Abstract available

  107. LUO L, Huang Y, Liang X, Ji Y, et al
    Susceptibility-guided therapy for Helicobacter pylori-infected penicillin-allergic patients: A prospective clinical trial of first-line and rescue therapies.
    Helicobacter. 2020 May 19:e12699. doi: 10.1111/hel.12699.
    PubMed     Abstract available

  108. JEHANNE Q, Benejat L, Megraud F, Bessede E, et al
    Evaluation of the Allplex H pylori and ClariR PCR Assay for Helicobacter pylori detection on gastric biopsies.
    Helicobacter. 2020 May 19:e12702. doi: 10.1111/hel.12702.
    PubMed     Abstract available

  109. ZHANG J, Chen Y, Chen W, Xu H, et al
    Persistent infection of Helicobacter pylori affects weight loss in obese population compared with persistent negative: A case-control study based on healthy Chinese.
    Helicobacter. 2020 May 15:e12697. doi: 10.1111/hel.12697.
    PubMed     Abstract available

  110. MIFTAHUSSURUR M, Waskito LA, El-Serag HB, Ajami NJ, et al
    Gastric microbiota and Helicobacter pylori in Indonesian population.
    Helicobacter. 2020 May 12:e12695. doi: 10.1111/hel.12695.
    PubMed     Abstract available

  111. HORIE R, Handa O, Ando T, Ose T, et al
    Helicobacter pylori eradication therapy outcome according to clarithromycin susceptibility testing in Japan.
    Helicobacter. 2020 May 5:e12698. doi: 10.1111/hel.12698.
    PubMed     Abstract available

    April 2020
  112. KAJI E, Yoden A, Otani M, Okuhira T, et al
    Helicobacter pylori test-and-treat strategy for second-year junior high school students aimed at the prevention of gastric cancer in Takatsuki City.
    Helicobacter. 2020 Apr 30:e12696. doi: 10.1111/hel.12696.
    PubMed     Abstract available

  113. GAO CP, Zhang D, Zhang T, Wang JX, et al
    PPI-amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta-analysis.
    Helicobacter. 2020 Apr 20:e12692. doi: 10.1111/hel.12692.
    PubMed     Abstract available

  114. BERESNIAK A, Malfertheiner P, Franceschi F, Liebaert F, et al
    Helicobacter pylori "Test-and-Treat" strategy with urea breath test: A cost-effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain-Results of the Hp-Breath initiative.
    Helicobacter. 2020 Apr 13:e12693. doi: 10.1111/hel.12693.
    PubMed     Abstract available

  115. BAYRAK NA, Tutar E, Volkan B, Sahin Akkelle B, et al
    Helicobacter pylori infection in children with celiac disease: Multi-center, cross-sectional study.
    Helicobacter. 2020 Apr 1:e12691. doi: 10.1111/hel.12691.
    PubMed     Abstract available

    March 2020
  116. KAKIUCHI T, Mizoe A, Yamamoto K, Imamura I, et al
    Effect of probiotics during vonoprazan-containing triple therapy on gut microbiota in Helicobacter pylori infection: A randomized controlled trial.
    Helicobacter. 2020 Mar 24:e12690. doi: 10.1111/hel.12690.
    PubMed     Abstract available

  117. DOORAKKERS E, Lagergren J, Santoni G, Engstrand L, et al
    Helicobacter pylori eradication treatment and the risk of Barrett's esophagus and esophageal adenocarcinoma.
    Helicobacter. 2020 Mar 16:e12688. doi: 10.1111/hel.12688.
    PubMed     Abstract available

  118. NYSSEN OP, Perez-Aisa A, Tepes B, Rodrigo-Saez L, et al
    Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg).
    Helicobacter. 2020 Mar 16:e12686. doi: 10.1111/hel.12686.
    PubMed     Abstract available

  119. ALBERTS CJ, Jeske R, de Martel C, den Hollander WJ, et al
    Helicobacter pylori seroprevalence in six different ethnic groups living in Amsterdam: The HELIUS study.
    Helicobacter. 2020 Mar 9:e12687. doi: 10.1111/hel.12687.
    PubMed     Abstract available

  120. YOON K, Kim N, Lee JW, Yoon H, et al
    Annual eradication rate of bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: A 15-year prospective study at a tertiary hospital in Korea.
    Helicobacter. 2020 Mar 6:e12685. doi: 10.1111/hel.12685.
    PubMed     Abstract available

    February 2020
  121. ARSHAD U, Sarkar S, Alipour Talesh G, Sutton P, et al
    A lack of role for antibodies in regulating Helicobacter pylori colonization and associated gastritis.
    Helicobacter. 2020 Feb 23:e12681. doi: 10.1111/hel.12681.
    PubMed     Abstract available

  122. LUO M, Hao Y, Tang M, Shi M, et al
    Application of a social media platform as a patient reminder in the treatment of Helicobacter pylori.
    Helicobacter. 2020 Feb 23:e12682. doi: 10.1111/hel.12682.
    PubMed     Abstract available

  123. HAMIDI S, Badmasti F, Sadeghpour Heravi F, Safapoor MH, et al
    Antibiotic resistance and clonal relatedness of Helicobacter pylori strains isolated from stomach biopsy specimens in northeast of Iran.
    Helicobacter. 2020 Feb 19:e12684. doi: 10.1111/hel.12684.
    PubMed     Abstract available

  124. KIM JY, Lee SY, Kim JH, Sung IK, et al
    Efficacy and safety of twice a day, bismuth-containing quadruple therapy using high-dose tetracycline and metronidazole for second-line Helicobacter pylori eradication.
    Helicobacter. 2020 Feb 19:e12683. doi: 10.1111/hel.12683.
    PubMed     Abstract available

  125. SELIGOVA B, Lukac L, Babelova M, Vavrova S, et al
    Diagnostic reliability of nested PCR depends on the primer design and threshold abundance of Helicobacter pylori in biopsy, stool, and saliva samples.
    Helicobacter. 2020 Feb 14:e12680. doi: 10.1111/hel.12680.
    PubMed     Abstract available

    January 2020
  126. ZHOU Y, Ye Z, Wang Y, Zhang Y, et al
    Comparison of four different regimens against Helicobacter pylori as a first-line treatment: A prospective, cross-sectional, comparative, open trial in Chinese children.
    Helicobacter. 2020 Jan 20:e12679. doi: 10.1111/hel.12679.
    PubMed     Abstract available

    December 2019
  127. KADKHODAEI S, Siavoshi F, Akbari Noghabi K
    Mucoid and coccoid Helicobacter pylori with fast growth and antibiotic resistance.
    Helicobacter. 2019 Dec 26:e12678. doi: 10.1111/hel.12678.
    PubMed     Abstract available

  128. SHAMSDIN SA, Alborzi A, Ghaderi A, Lankrani KB, et al
    Significance of TC9 and TH9 in Helicobacter pylori-induced gastritis.
    Helicobacter. 2019 Dec 5:e12672. doi: 10.1111/hel.12672.
    PubMed     Abstract available

    November 2019
  129. MIAO R, Wan C, Wang Z
    The relationship of gastric microbiota and Helicobacter pylori infection in pediatrics population.
    Helicobacter. 2019 Nov 24:e12676. doi: 10.1111/hel.12676.
    PubMed     Abstract available

  130. BUTT J, Blot WJ, Shrubsole MJ, Varga MG, et al
    Performance of multiplex serology in discriminating active vs past Helicobacter pylori infection in a primarily African American population in the southeastern United States.
    Helicobacter. 2019 Nov 20:e12671. doi: 10.1111/hel.12671.
    PubMed     Abstract available

  131. MUHSEN K, Na'amnih W, Adler A, Carmeli Y, et al
    Clostridium difficile-associated disease and Helicobacter pylori seroprevalence: A case-control study.
    Helicobacter. 2019 Nov 13:e12668. doi: 10.1111/hel.12668.
    PubMed     Abstract available

  132. ROCHA GA, de Melo FF, Cabral MMDA, de Brito BB, et al
    Interleukin-27 is abrogated in gastric cancer, but highly expressed in other Helicobacter pylori-associated gastroduodenal diseases.
    Helicobacter. 2019 Nov 8:e12667. doi: 10.1111/hel.12667.
    PubMed     Abstract available

  133. KOCSMAR E, Kocsmar I, Buzas GM, Szirtes I, et al
    Helicobacter pylori heteroresistance to clarithromycin in adults-New data by in situ detection and improved concept.
    Helicobacter. 2019 Nov 8:e12670. doi: 10.1111/hel.12670.
    PubMed     Abstract available

  134. PAPAEFTHYMIOU A, Liatsos C, Georgopoulos SD, Apostolopoulos P, et al
    Helicobacter pylori eradication regimens in an antibiotic high-resistance European area: A cost-effectiveness analysis.
    Helicobacter. 2019 Nov 6:e12666. doi: 10.1111/hel.12666.
    PubMed     Abstract available

  135. KISHIKAWA H, Ojiro K, Nakamura K, Katayama T, et al
    Previous Helicobacter pylori infection-induced atrophic gastritis: A distinct disease entity in an understudied population without a history of eradication.
    Helicobacter. 2019 Nov 3:e12669. doi: 10.1111/hel.12669.
    PubMed     Abstract available

    October 2019
  136. PONZETTO A, Figura N
    Prevalence of ischemic stroke and Helicobacter pylori infection.
    Helicobacter. 2019 Oct 27:e12664. doi: 10.1111/hel.12664.

  137. GUO Y, Zhang T, Shi Y, Zhang J, et al
    Helicobacter pylori inhibits GKN1 expression via the CagA/p-ERK/AUF1 pathway.
    Helicobacter. 2019 Oct 27:e12665. doi: 10.1111/hel.12665.
    PubMed     Abstract available

  138. YU Y, Yao X, Liang J, Lu C, et al
    Is Helicobacter pylori associated with Behcet's syndrome? A meta-analysis.
    Helicobacter. 2019 Oct 16:e12663. doi: 10.1111/hel.12663.
    PubMed     Abstract available

  139. SONG C, Xie C, Zhu Y, Liu W, et al
    Management of Helicobacter pylori infection by clinicians: A nationwide survey in a developing country.
    Helicobacter. 2019 Oct 1:e12656. doi: 10.1111/hel.12656.
    PubMed     Abstract available

    September 2019
  140. DE SENA-REIS JS, Bezerra DD, Figueiredo CA, Barreto ML, et al
    Relationship between African Biogeographical Ancestry and Helicobacter pylori infection in children of a large Latin American urban center.
    Helicobacter. 2019 Sep 30:e12662. doi: 10.1111/hel.12662.
    PubMed     Abstract available

  141. KIM HJ, Kim YJ, Lee HJ, Hong JY, et al
    Systematic review and meta-analysis: Effect of Helicobacter pylori eradication on chronic spontaneous urticaria.
    Helicobacter. 2019 Sep 15:e12661. doi: 10.1111/hel.12661.
    PubMed     Abstract available

  142. LEE JY, Kim N, Nam RH, In Choi S, et al
    Primary and secondary antibiotic resistance of Helicobacter pylori in Korea from 2003 to 2018.
    Helicobacter. 2019 Sep 11:e12660. doi: 10.1111/hel.12660.
    PubMed     Abstract available

  143. DORE MP, Bibbo S, Loria M, Salis R, et al
    Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera(R) or Lactobacillus reuteri for treatment naive or for retreatment of Helicobacter pylori. Two randomized pilot studies.
    Helicobacter. 2019 Sep 9:e12659. doi: 10.1111/hel.12659.
    PubMed     Abstract available

  144. AKTER S, Jeverstam F, Lundgren A, Magnusson MK, et al
    The frequency of circulating integrin alpha4beta7(+) cells correlates with protection against Helicobacter pylori infection in immunized mice.
    Helicobacter. 2019 Sep 9:e12658. doi: 10.1111/hel.12658.
    PubMed     Abstract available

  145. MAKRISTATHIS A, Hirschl AM, Megraud F, Bessede E, et al
    Review: Diagnosis of Helicobacter pylori infection.
    Helicobacter. 2019;24 Suppl 1:e12641.
    PubMed     Abstract available

  146. MISAK Z, Hojsak I, Homan M
    Review: Helicobacter pylori in pediatrics.
    Helicobacter. 2019;24 Suppl 1:e12639.
    PubMed     Abstract available

  147. LEJA M, Grinberga-Derica I, Bilgilier C, Steininger C, et al
    Review: Epidemiology of Helicobacter pylori infection.
    Helicobacter. 2019;24 Suppl 1:e12635.
    PubMed     Abstract available

  148. FRANCESCHI F, Covino M, Roubaud Baudron C
    Review: Helicobacter pylori and extragastric diseases.
    Helicobacter. 2019;24 Suppl 1:e12636.
    PubMed     Abstract available

  149. BOLTIN D, Niv Y, Schutte K, Schulz C, et al
    Review: Helicobacter pylori and non-malignant upper gastrointestinal diseases.
    Helicobacter. 2019;24 Suppl 1:e12637.
    PubMed     Abstract available

  150. O'CONNOR A, Liou JM, Gisbert JP, O'Morain C, et al
    Review: Treatment of Helicobacter pylori Infection 2019.
    Helicobacter. 2019;24 Suppl 1:e12640.
    PubMed     Abstract available

  151. CHMIELA M, Kupcinskas J
    Review: Pathogenesis of Helicobacter pylori infection.
    Helicobacter. 2019;24 Suppl 1:e12638.
    PubMed     Abstract available

    August 2019
  152. XU N, Ruan G, Liu W, Hu C, et al
    Vaccine-induced gastric CD4(+) tissue-resident memory T cells proliferate in situ to amplify immune response against Helicobacter pylori insult.
    Helicobacter. 2019 Aug 14:e12652. doi: 10.1111/hel.12652.
    PubMed     Abstract available

  153. ZHOU BG, Chen LX, Li B, Wan LY, et al
    Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis.
    Helicobacter. 2019 Aug 14:e12651. doi: 10.1111/hel.12651.
    PubMed     Abstract available

  154. YANG L, He X, Li L, Lu C, et al
    Effect of vitamin D on Helicobacter pylori infection and eradication: A meta-analysis.
    Helicobacter. 2019 Aug 14:e12655. doi: 10.1111/hel.12655.
    PubMed     Abstract available

  155. KRZYSIEK-MACZKA G, Wrobel T, Targosz A, Szczyrk U, et al
    Helicobacter pylori-activated gastric fibroblasts induce epithelial-mesenchymal transition of gastric epithelial cells in vitro in a TGF-beta-dependent manner.
    Helicobacter. 2019 Aug 14:e12653. doi: 10.1111/hel.12653.
    PubMed     Abstract available

  156. ONG S, Kim SE, Kim JH, Yi NH, et al
    Helicobacter pylori eradication rates with concomitant and tailored therapy based on 23S rRNA point mutation: A multicenter randomized controlled trial.
    Helicobacter. 2019 Aug 14:e12654. doi: 10.1111/hel.12654.
    PubMed     Abstract available

  157. KIM BJ, Yang CH, Song HJ, Jeon SW, et al
    Online registry for nationwide database of Helicobacter pylori eradication in Korea: Correlation of antibiotic use density with eradication success.
    Helicobacter. 2019 Aug 1:e12646. doi: 10.1111/hel.12646.
    PubMed     Abstract available

    July 2019
  158. ZHOU H, Sun H, Liu X, Chen J, et al
    Combined effect between WT1 methylation and Helicobacter pylori infection, smoking, and alcohol consumption on the risk of gastric cancer.
    Helicobacter. 2019 Jul 30:e12650. doi: 10.1111/hel.12650.
    PubMed     Abstract available

  159. GU Y, Zheng L, Kumari S, Zhang Q, et al
    The relationship between Helicobacter pylori infection and depressive symptoms in the general population in China: The TCLSIH cohort study.
    Helicobacter. 2019 Jul 22:e12632. doi: 10.1111/hel.12632.
    PubMed     Abstract available

  160. WIESE-SZADKOWSKA M, Helmin-Basa A, Eljaszewicz A, Gackowska L, et al
    Selected commensal bacteria change profiles of Helicobacter pylori-induced T cells via dendritic cell modulation.
    Helicobacter. 2019 Jul 21:e12614. doi: 10.1111/hel.12614.
    PubMed     Abstract available

  161. NAHM JH, Kim WK, Kwon Y, Kim H, et al
    Detection of Helicobacter pylori with clarithromycin resistance-associated mutations using peptide nucleic acid probe-based melting point analysis.
    Helicobacter. 2019 Jul 14:e12634. doi: 10.1111/hel.12634.
    PubMed     Abstract available

  162. FU L, Xie C
    A lucid review of Helicobacter pylori-induced DNA damage in gastric cancer.
    Helicobacter. 2019 Jul 11:e12631. doi: 10.1111/hel.12631.
    PubMed     Abstract available

  163. LU HH, Lai FP, Lo HY, Sheu BS, et al
    Increasing antimicrobial resistance to clarithromycin and metronidazole in pediatric Helicobacter pylori infection in southern Taiwan: A comparison between two decades.
    Helicobacter. 2019 Jul 11:e12633. doi: 10.1111/hel.12633.
    PubMed     Abstract available

  164. BURGARD M, Kotilea K, Mekhael J, Miendje-Deyi VY, et al
    Evolution of Helicobacter pylori associated with gastroduodenal ulcers or erosions in children over the past 23 years: Decline or steady state?
    Helicobacter. 2019 Jul 8:e12629. doi: 10.1111/hel.12629.
    PubMed     Abstract available

  165. MCNICHOLL AG, O'Morain CA, Megraud F, Gisbert JP, et al
    Protocol of the European Registry on the management of Helicobacter pylori infection (Hp-EuReg).
    Helicobacter. 2019 Jul 8:e12630. doi: 10.1111/hel.12630.
    PubMed     Abstract available

  166. AUTTAJAROON J, Vilaichone RK, Chotivitayatarakorn P, Mahachai V, et al
    Once-daily rabeprazole, levofloxacin, clarithromycin-MR, and bismuth for Helicobacter pylori eradication: A randomized study of 7 or 14 days (ONCE study).
    Helicobacter. 2019 Jul 7:e12615. doi: 10.1111/hel.12615.
    PubMed     Abstract available

  167. SALEHI N, Attaran B, Eskini N, Esmaeili M, et al
    New insights into resistance of Helicobacter pylori against third- and fourth-generation fluoroquinolones: A molecular docking study of prevalent GyrA mutations.
    Helicobacter. 2019 Jul 7:e12628. doi: 10.1111/hel.12628.
    PubMed     Abstract available

    June 2019
  168. CICCAGLIONE AF, Cellini L, Marzio L
    Pylera(R) plus ranitidine vs Pylera(R) plus esomeprazole in first-line treatment of Helicobacter pylori infection: Two pilot studies.
    Helicobacter. 2019 Jun 5:e12606. doi: 10.1111/hel.12606.
    PubMed     Abstract available

    May 2019
  169. HE C, Peng C, Wang H, Ouyang Y, et al
    The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults.
    Helicobacter. 2019 May 23:e12590. doi: 10.1111/hel.12590.
    PubMed     Abstract available

  170. GU L, Li S, He Y, Chen Y, et al
    Bismuth, rabeprazole, amoxicillin, and doxycycline as first-line Helicobacter pylori therapy in clinical practice: A pilot study.
    Helicobacter. 2019 May 22:e12594. doi: 10.1111/hel.12594.
    PubMed     Abstract available

  171. SONG C, Qian X, Zhu Y, Shu X, et al
    Effectiveness and safety of furazolidone-containing quadruple regimens in patients with Helicobacter pylori infection in real-world practice.
    Helicobacter. 2019 May 20:e12591. doi: 10.1111/hel.12591.
    PubMed     Abstract available

  172. MCNICHOLL AG, Amador J, Ricote M, Canones-Garzon PJ, et al
    Spanish primary care survey on the management of Helicobacter pylori infection and dyspepsia: Information, attitudes, and decisions.
    Helicobacter. 2019 May 20:e12593. doi: 10.1111/hel.12593.
    PubMed     Abstract available

  173. ORTIZ V, Estevez-Ordonez D, Montalvan-Sanchez E, Urrutia-Argueta S, et al
    Helicobacter pylori antimicrobial resistance and antibiotic consumption in the low-resource Central America setting.
    Helicobacter. 2019 May 20:e12595. doi: 10.1111/hel.12595.
    PubMed     Abstract available

  174. KATO M, Ota H, Okuda M, Kikuchi S, et al
    Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition.
    Helicobacter. 2019 May 20:e12597. doi: 10.1111/hel.12597.
    PubMed     Abstract available

  175. YU L, Luo L, Long X, Liang X, et al
    High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trial.
    Helicobacter. 2019 May 20:e12596. doi: 10.1111/hel.12596.
    PubMed     Abstract available

  176. LEE JH, Ahn JY, Choi KD, Jung HY, et al
    Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: A prospective multicenter study.
    Helicobacter. 2019 May 20:e12592. doi: 10.1111/hel.12592.
    PubMed     Abstract available

  177. OGAWA T, Wada Y, Takemura K, Board PG, et al
    CHAC1 overexpression in human gastric parietal cells with Helicobacter pylori infection in the secretory canaliculi.
    Helicobacter. 2019 May 20:e12598. doi: 10.1111/hel.12598.
    PubMed     Abstract available

  178. DAWSON EM, Dunne KA, Richardson EJ, Praszkier J, et al
    Complete genome sequence of Helicobacter pylori B128 7.13 and a single-step method for the generation of unmarked mutations.
    Helicobacter. 2019 May 7:e12587. doi: 10.1111/hel.12587.
    PubMed     Abstract available

    April 2019
  179. BANG CS, Lee JJ, Baik GH
    The most influential articles in Helicobacter pylori research: A bibliometric analysis.
    Helicobacter. 2019 Apr 29:e12589. doi: 10.1111/hel.12589.
    PubMed     Abstract available

  180. BAYLINA M, Munoz N, Sanchez-Delgado J, Lopez-Gongora S, et al
    Systematic review: Would susceptibility-guided treatment achieve acceptable cure rates for second-line Helicobacter pylori therapy as currently practiced?
    Helicobacter. 2019 Apr 16:e12584. doi: 10.1111/hel.12584.
    PubMed     Abstract available

  181. KUO HY, Chang WL, Yeh YC, Cheng HC, et al
    Spasmolytic polypeptide-expressing metaplasia associated with higher expressions of miR-21, 155, and 223 can be regressed by Helicobacter pylori eradication in the gastric cancer familial relatives.
    Helicobacter. 2019 Apr 16:e12578. doi: 10.1111/hel.12578.
    PubMed     Abstract available

  182. KWON YH, Jeon SW, Nam SY, Lee HS, et al
    Efficacy of tailored therapy for Helicobacter pylori eradication based on clarithromycin resistance and survey of previous antibiotic exposure: A single-center prospective pilot study.
    Helicobacter. 2019 Apr 10:e12585. doi: 10.1111/hel.12585.
    PubMed     Abstract available

  183. POLYZOS SA, Kountouras J
    Helicobacter pylori infection and nonalcoholic fatty liver disease: Time for large clinical trials evaluating eradication therapy.
    Helicobacter. 2019 Apr 5:e12588. doi: 10.1111/hel.12588.

  184. LAREDO V, Sostres C, Alfaro E, Arroyo MT, et al
    Management of Helicobacter pylori infection at the primary care level. The implementation of specific counseling improves eradication rates.
    Helicobacter. 2019 Apr 5:e12586. doi: 10.1111/hel.12586.
    PubMed     Abstract available

  185. UOTANI T, Murakami K, Uchida T, Tanaka S, et al
    Changes of tight junction and interleukin-8 expression using a human gastroid monolayer model of Helicobacter pylori infection.
    Helicobacter. 2019 Apr 5:e12583. doi: 10.1111/hel.12583.
    PubMed     Abstract available

  186. PENG C, Li NS, Hu Y, Lu NH, et al
    Impact factors that modulate gastric cancer risk in Helicobacter pylori-infected rodent models.
    Helicobacter. 2019 Apr 4:e12580. doi: 10.1111/hel.12580.
    PubMed     Abstract available

  187. YAN W, Gu L, Ren W, Ma X, et al
    Recognition of Helicobacter pylori by protein-targeting aptamers.
    Helicobacter. 2019 Apr 4:e12577. doi: 10.1111/hel.12577.
    PubMed     Abstract available

  188. VESGA FJ, Moreno Y, Ferrus MA, Ledesma-Gaitan LM, et al
    Correlation among fecal indicator bacteria and physicochemical parameters with the presence of Helicobacter pylori DNA in raw and drinking water from Bogota, Colombia.
    Helicobacter. 2019 Apr 4:e12582. doi: 10.1111/hel.12582.
    PubMed     Abstract available

  189. GUVEN B, Gulerman F, Kacmaz B
    Helicobacter pylori resistance to clarithromycin and fluoroquinolones in a pediatric population in Turkey: A cross-sectional study.
    Helicobacter. 2019 Apr 4:e12581. doi: 10.1111/hel.12581.
    PubMed     Abstract available

    March 2019
  190. ZHOU BG, Yang HJ, Xu W, Wang K, et al
    Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: A systematic review and meta-analysis of observational studies.
    Helicobacter. 2019 Mar 25:e12576. doi: 10.1111/hel.12576.
    PubMed     Abstract available

  191. SOUZA MJ, de Moraes JA, Da Silva VN, Helal-Neto E, et al
    Helicobacter pylori urease induces pro-inflammatory effects and differentiation of human endothelial cells: Cellular and molecular mechanism.
    Helicobacter. 2019 Mar 25:e12573. doi: 10.1111/hel.12573.
    PubMed     Abstract available

  192. OKUDA M, Lin Y, Wang C, Kakiuchi T, et al
    Metronidazole for Helicobacter pylori eradication therapy among children and adolescents in Japan: Overcoming controversies and concerns.
    Helicobacter. 2019 Mar 15:e12575. doi: 10.1111/hel.12575.
    PubMed     Abstract available

  193. AREVALO GALVIS A, Trespalacios Rangel AA, Otero Regino W
    Personalized therapy for Helicobacter pylori: CYP2C19 genotype effect on first-line triple therapy.
    Helicobacter. 2019 Mar 11:e12574. doi: 10.1111/hel.12574.
    PubMed     Abstract available

  194. WANG T, Yang X, Li Y, Li L, et al
    Twice daily short-message-based re-education could improve Helicobacter pylori eradication rate in young population: A prospective randomized controlled study.
    Helicobacter. 2019 Mar 8:e12569. doi: 10.1111/hel.12569.
    PubMed     Abstract available

    February 2019
  195. HSIEH MS, Liu CJ, Hsu WH, Li CJ, et al
    Gastric juice-based PCR assay: An alternative testing method to aid in the management of previously treated Helicobacter pylori infection.
    Helicobacter. 2019 Feb 28:e12568. doi: 10.1111/hel.12568.
    PubMed     Abstract available

  196. LU B, Wang J, Li J, Liu L, et al
    Half-dose clarithromycin-containing bismuth quadruple therapy is effective and economical in treating Helicobacter pylori infection: A single-center, open-label, randomized trial.
    Helicobacter. 2019 Feb 19:e12566. doi: 10.1111/hel.12566.
    PubMed     Abstract available

  197. NYSSEN OP, McNicholl AG, Gisbert JP
    Meta-analysis of three-in-one single capsule bismuth-containing quadruple therapy for the eradication of Helicobacter pylori.
    Helicobacter. 2019 Feb 14:e12570. doi: 10.1111/hel.12570.
    PubMed     Abstract available

  198. ZHAO Y, Gao X, Guo J, Yu D, et al
    Helicobacter pylori infection alters gastric and tongue coating microbial communities.
    Helicobacter. 2019 Feb 7:e12567. doi: 10.1111/hel.12567.
    PubMed     Abstract available

    January 2019
  199. KO SW, Kim YJ, Chung WC, Lee SJ, et al
    Bismuth supplements as the first-line regimen for Helicobacter pylori eradication therapy: Systemic review and meta-analysis.
    Helicobacter. 2019 Jan 30:e12565. doi: 10.1111/hel.12565.
    PubMed     Abstract available

  200. CHEN Q, Liang X, Long X, Yu L, et al
    Cost-effectiveness analysis of screen-and-treat strategy in asymptomatic Chinese for preventing Helicobacter pylori-associated diseases.
    Helicobacter. 2019 Jan 22:e12563. doi: 10.1111/hel.12563.
    PubMed     Abstract available

  201. ZHAN Y, Si M, Li M, Jiang Y, et al
    The risk of Helicobacter pylori infection for adverse pregnancy outcomes: A systematic review and meta-analysis.
    Helicobacter. 2019 Jan 22:e12562. doi: 10.1111/hel.12562.
    PubMed     Abstract available

  202. LEE JW, Kim N, Nam RH, Lee SM, et al
    Favorable outcomes of culture-based Helicobacter pylori eradication therapy in a region with high antimicrobial resistance.
    Helicobacter. 2019 Jan 10:e12561. doi: 10.1111/hel.12561.
    PubMed     Abstract available

    December 2018
  203. HAYS C, Delerue T, Lamarque D, Burucoa C, et al
    Molecular diagnosis of Helicobacter pylori infection in gastric biopsies: Evaluation of the Amplidiag((R)) H. pylori + ClariR assay.
    Helicobacter. 2018 Dec 12:e12560. doi: 10.1111/hel.12560.
    PubMed     Abstract available

  204. HONMA H, Nakayama Y, Kato S, Hidaka N, et al
    Clinical features of Helicobacter pylori antibody-positive junior high school students in Nagano Prefecture, Japan.
    Helicobacter. 2018 Dec 4:e12559. doi: 10.1111/hel.12559.
    PubMed     Abstract available

    November 2018
  205. COSME A, Torrente Iranzo S, Montes Ros M, Fernandez-Reyes Silvestre M, et al
    Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies.
    Helicobacter. 2018 Nov 20:e12557. doi: 10.1111/hel.12557.
    PubMed     Abstract available

  206. NESHANI A, Zare H, Akbari Eidgahi MR, Hooshyar Chichaklu A, et al
    Review of antimicrobial peptides with anti-Helicobacter pylori activity.
    Helicobacter. 2018 Nov 15:e12555. doi: 10.1111/hel.12555.
    PubMed     Abstract available

  207. ANBARI F, Ashouri Moghaddam A, Sabeti E, Khodabakhshi A, et al
    Halitosis: Helicobacter pylori or oral factors.
    Helicobacter. 2018 Nov 15:e12556. doi: 10.1111/hel.12556.
    PubMed     Abstract available

  208. GRAHAM DY, Lu H, Dore MP
    Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI.
    Helicobacter. 2018 Nov 15:e12554. doi: 10.1111/hel.12554.
    PubMed     Abstract available

  209. SZAFLARSKA-POPLAWSKA A, Soroczynska-Wrzyszcz A
    Prevalence of Helicobacter pylori infection among junior high school students in Grudziadz, Poland.
    Helicobacter. 2018 Nov 15:e12552. doi: 10.1111/hel.12552.
    PubMed     Abstract available

  210. SHINDLER-ITSKOVITCH T, Chodick G, Shalev V, Muhsen K, et al
    Helicobacter pylori infection and prevalence of stroke.
    Helicobacter. 2018 Nov 15:e12553. doi: 10.1111/hel.12553.
    PubMed     Abstract available

  211. SIA R, Plouzeau C, Godonou HSM, Guingane A, et al
    Low-level primary clarithromycin resistance of Helicobacter pylori in Burkina Faso: A prospective molecular study.
    Helicobacter. 2018 Nov 12:e12551. doi: 10.1111/hel.12551.

  212. PONZETTO A, Holton J
    Extragastric diseases correlated with Helicobacter pylori.
    Helicobacter. 2018 Nov 9:e12549. doi: 10.1111/hel.12549.

  213. WU YY, Hsieh CT, Tsay GJ, Kao JT, et al
    Recruitment of CCR6(+ ) Foxp3(+) regulatory gastric infiltrating lymphocytes in Helicobacter pylori gastritis.
    Helicobacter. 2018 Nov 9:e12550. doi: 10.1111/hel.12550.
    PubMed     Abstract available

    October 2018
  214. MACIAS-GARCIA F, Baston-Rey I, de la Iglesia-Garcia D, Calvino-Suarez C, et al
    Bismuth-containing quadruple therapy versus concomitant quadruple therapy as first-line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: A prospective, cross-sectional, comparative, open trial.
    Helicobacter. 2018 Oct 22:e12546. doi: 10.1111/hel.12546.
    PubMed     Abstract available

  215. DEKHNICH N, Ivanchik N, Kozlov R, Alimov A, et al
    Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation.
    Helicobacter. 2018 Oct 16:e12545. doi: 10.1111/hel.12545.
    PubMed     Abstract available

  216. CHAUHAN N, Tay ACY, Marshall BJ, Jain U, et al
    Helicobacter pylori VacA, a distinct toxin exerts diverse functionalities in numerous cells: An overview.
    Helicobacter. 2018 Oct 16:e12544. doi: 10.1111/hel.12544.
    PubMed     Abstract available

  217. MURATA M, Sugimoto M, Otsuka T, Nishida A, et al
    Successful Helicobacter pylori eradication therapy improves symptoms of chronic constipation.
    Helicobacter. 2018 Oct 15:e12543. doi: 10.1111/hel.12543.
    PubMed     Abstract available

  218. GOTODA T, Takano C, Kusano C, Suzuki S, et al
    Gut microbiome can be restored without adverse events after Helicobacter pylori eradication therapy in teenagers.
    Helicobacter. 2018 Oct 12:e12541. doi: 10.1111/hel.12541.
    PubMed     Abstract available

  219. ALI B, Chloe W, Mehmet A, Sofie B, et al
    Presence of gastric Helicobacter species in children suffering from gastric disorders in Southern Turkey.
    Helicobacter. 2018;23:e12511.
    PubMed     Abstract available

    September 2018
  220. EROSS B, Tinusz B, Farkas N, Hegyi P, et al
    Does Helicobacter pylori infection increase the risk of Barrett's esophagus and esophageal adenocarcinoma?
    Helicobacter. 2018 Sep 24:e12539. doi: 10.1111/hel.12539.

  221. ABDEL-RAZIK A, Mousa N, Shabana W, Refaey M, et al
    Helicobacter pylori and non-alcoholic fatty liver disease: A new enigma?
    Helicobacter. 2018 Sep 23:e12537. doi: 10.1111/hel.12537.
    PubMed     Abstract available

  222. KRZYSIEK-MACZKA G, Targosz A, Szczyrk U, Strzalka M, et al
    Role of Helicobacter pylori infection in cancer-associated fibroblast-induced epithelial-mesenchymal transition in vitro.
    Helicobacter. 2018 Sep 23:e12538. doi: 10.1111/hel.12538.
    PubMed     Abstract available

  223. FEDER R, Posner S, Qin Y, Zheng J, et al
    Helicobacter pylori-associated peptic ulcer disease: A retrospective analysis of post-treatment testing practices.
    Helicobacter. 2018 Sep 23:e12540. doi: 10.1111/hel.12540.
    PubMed     Abstract available

  224. SIAVOSHI F, Saniee P, Malekzadeh R
    Effective antimicrobial activity of rifabutin against multidrug-resistant Helicobacter pylori.
    Helicobacter. 2018 Sep 19:e12531. doi: 10.1111/hel.12531.
    PubMed     Abstract available

  225. DOULBERIS M, Kountouras J, Polyzos SA, Tzivras D, et al
    Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on gastroesophageal reflux disease- Barrett's esophagus- esophageal adenocarcinoma sequence.
    Helicobacter. 2018 Sep 12:e12534. doi: 10.1111/hel.12534.

  226. LUO S, Liu W, Zeng Z, Ye F, et al
    Toxic adjuvants alter the function and phenotype of dendritic cells to initiate adaptive immune responses induced by oral Helicobacter pylori vaccines.
    Helicobacter. 2018 Sep 11:e12536. doi: 10.1111/hel.12536.
    PubMed     Abstract available

  227. YANG-OU YB, Hu Y, Zhu Y, Lu NH, et al
    The effect of antioxidants on Helicobacter pylori eradication: A systematic review with meta-analysis.
    Helicobacter. 2018 Sep 6:e12535. doi: 10.1111/hel.12535.
    PubMed     Abstract available

  228. HU Y, He C, Liu JP, Li NS, et al
    Analysis of key genes and signaling pathways involved in Helicobacter pylori-associated gastric cancer based on The Cancer Genome Atlas database and RNA sequencing data.
    Helicobacter. 2018 Sep 2:e12530. doi: 10.1111/hel.12530.
    PubMed     Abstract available

  229. KORI M, Daugule I, Urbonas V
    Helicobacter pylori and some aspects of gut microbiota in children.
    Helicobacter. 2018;23 Suppl 1:e12524.
    PubMed     Abstract available

  230. RAZUKA-EBELA D, Giupponi B, Franceschi F
    Helicobacter pylori and extragastric diseases.
    Helicobacter. 2018;23 Suppl 1:e12520.
    PubMed     Abstract available

  231. SJOMINA O, Pavlova J, Niv Y, Leja M, et al
    Epidemiology of Helicobacter pylori infection.
    Helicobacter. 2018;23 Suppl 1:e12514.
    PubMed     Abstract available

  232. O'MORAIN NR, Dore MP, O'Connor AJP, Gisbert JP, et al
    Treatment of Helicobacter pylori infection in 2018.
    Helicobacter. 2018;23 Suppl 1:e12519.
    PubMed     Abstract available

  233. SKREBINSKA S, Megraud F, Bessede E
    Diagnosis of Helicobacter pylori infection.
    Helicobacter. 2018;23 Suppl 1:e12515.
    PubMed     Abstract available

  234. JONAITIS L, Pellicano R, Kupcinskas L
    Helicobacter pylori and nonmalignant upper gastrointestinal diseases.
    Helicobacter. 2018;23 Suppl 1:e12522.
    PubMed     Abstract available

  235. WASKITO LA, Salama NR, Yamaoka Y
    Pathogenesis of Helicobacter pylori infection.
    Helicobacter. 2018;23 Suppl 1:e12516.
    PubMed     Abstract available

    August 2018
  236. CHENG HC, Liou JM, Luo JC, Chiu CT, et al
    The implementation of the consensus on the management of Helicobacter pylori and barriers to consensus.
    Helicobacter. 2018 Aug 29:e12533. doi: 10.1111/hel.12533.
    PubMed     Abstract available

  237. BENEJAT L, Ducournau A, Lehours P, Megraud F, et al
    Real-time PCR for Helicobacter pylori diagnosis. The best tools available.
    Helicobacter. 2018 Aug 28:e12512. doi: 10.1111/hel.12512.
    PubMed     Abstract available

  238. LI Z, Ying X, Shan F, Ji J, et al
    The association of garlic with Helicobacter pylori infection and gastric cancer risk: A systematic review and meta-analysis.
    Helicobacter. 2018 Aug 28:e12532. doi: 10.1111/hel.12532.
    PubMed     Abstract available

  239. MCNICHOLL AG, Molina-Infante J, Lucendo AJ, Calleja JL, et al
    Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial.
    Helicobacter. 2018 Aug 23:e12529. doi: 10.1111/hel.12529.
    PubMed     Abstract available

  240. SILVA GM, Silva HM, Nascimento J, Goncalves JP, et al
    Helicobacter pylori antimicrobial resistance in a pediatric population.
    Helicobacter. 2018 Aug 9:e12528. doi: 10.1111/hel.12528.
    PubMed     Abstract available

    July 2018
  241. XIE Y, Zhang Z, Hong J, Liu W, et al
    Furazolidone-containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China.
    Helicobacter. 2018 Jul 22:e12496. doi: 10.1111/hel.12496.
    PubMed     Abstract available

    June 2018
  242. BASSAGH A, Hayatbakhsh Abasi M, Larussa T, Ghazizadeh M, et al
    Diminished circulating concentration of interleukin-35 in Helicobacter pylori-infected patients with peptic ulcer: Its association with FOXP3 gene polymorphism, bacterial virulence factor CagA, and gender of patients.
    Helicobacter. 2018 Jun 25:e12501. doi: 10.1111/hel.12501.
    PubMed     Abstract available

  243. EROSS B, Farkas N, Vincze A, Tinusz B, et al
    Helicobacter pylori infection reduces the risk of Barrett's esophagus: A meta-analysis and systematic review.
    Helicobacter. 2018 Jun 25:e12504. doi: 10.1111/hel.12504.
    PubMed     Abstract available

  244. SAKITANI K, Nishizawa T, Arita M, Yoshida S, et al
    Early detection of gastric cancer after Helicobacter pylori eradication due to endoscopic surveillance.
    Helicobacter. 2018 Jun 20:e12503. doi: 10.1111/hel.12503.
    PubMed     Abstract available

  245. ZAGARI RM, Romiti A, Ierardi E, Gravina AG, et al
    The "three-in-one" formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice.
    Helicobacter. 2018 Jun 20:e12502. doi: 10.1111/hel.12502.
    PubMed     Abstract available

  246. LOPO I, Libanio D, Pita I, Dinis-Ribeiro M, et al
    Helicobacter pylori antibiotic resistance in Portugal: Systematic review and meta-analysis.
    Helicobacter. 2018 Jun 17:e12493. doi: 10.1111/hel.12493.
    PubMed     Abstract available

  247. HSU PI, Pan CY, Kao JY, Tsay FW, et al
    Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
    Helicobacter. 2018 Jun 13:e12498. doi: 10.1111/hel.12498.
    PubMed     Abstract available

  248. ROBOTIS J, Tsiodras S, Rokkas T
    Helicobacter pylori eradication may successfully treat primary cutaneous follicle center lymphoma.
    Helicobacter. 2018 Jun 13:e12499. doi: 10.1111/hel.12499.

  249. GANTUYA B, Bolor D, Oyuntsetseg K, Erdene-Ochir Y, et al
    New observations regarding Helicobacter pylori and gastric cancer in Mongolia.
    Helicobacter. 2018 Jun 8:e12491. doi: 10.1111/hel.12491.
    PubMed     Abstract available

  250. UNLUSOY AKSU A, Yilmaz G, Egritas Gurkan O, Sari S, et al
    The effect of Helicobacter pylori eradication on functional dyspepsia in Turkish children.
    Helicobacter. 2018 Jun 6:e12497. doi: 10.1111/hel.12497.
    PubMed     Abstract available

  251. LI M, Oshima T, Horikawa T, Tozawa K, et al
    Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori.
    Helicobacter. 2018 Jun 6:e12495. doi: 10.1111/hel.12495.
    PubMed     Abstract available

  252. BLUMEL B, Goelz H, Kist M, Glocker EO, et al
    Retrospective study on outcome of salvage Helicobacter pylori eradication therapies based on molecular genetic susceptibility testing.
    Helicobacter. 2018 Jun 6:e12494. doi: 10.1111/hel.12494.
    PubMed     Abstract available

  253. RAMADAN M
    Eradication of Helicobacter pylori infection was associated with complete cure of resistant bleeding per gums.
    Helicobacter. 2018 Jun 5:e12492. doi: 10.1111/hel.12492.

    May 2018
  254. SABERI S, Pournasr B, Farzaneh Z, Esmaeili M, et al
    A simple and cost-efficient adherent culture platform for human gastric primary cells, as an in vitro model for Helicobacter pylori infection.
    Helicobacter. 2018 May 17:e12489. doi: 10.1111/hel.12489.
    PubMed     Abstract available

    April 2018
  255. LONG X, Chen Q, Yu L, Liang X, et al
    Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance.
    Helicobacter. 2018 Apr 25:e12485. doi: 10.1111/hel.12485.
    PubMed     Abstract available

  256. SAGHIER S, Schwarz SM, Anderson V, Gupta R, et al
    Pediatric Helicobacter pylori gastropathy demonstrates a unique pattern of gastric foveolar hyperplasia.
    Helicobacter. 2018 Apr 25:e12487. doi: 10.1111/hel.12487.
    PubMed     Abstract available

  257. MARCUS EA, Sachs G, Scott DR
    Acid-regulated gene expression of Helicobacter pylori: Insight into acid protection and gastric colonization.
    Helicobacter. 2018 Apr 25:e12490. doi: 10.1111/hel.12490.
    PubMed     Abstract available

  258. MUNOZ N, Sanchez-Delgado J, Baylina M, Puig I, et al
    Systematic review, meta-analysis, and meta-regression: Successful second-line treatment for Helicobacter pylori.
    Helicobacter. 2018 Apr 16:e12488. doi: 10.1111/hel.12488.
    PubMed     Abstract available

  259. YANG TT, Cao N, Zhang HH, Wei JB, et al
    Helicobacter pylori infection-induced H3Ser10 phosphorylation in stepwise gastric carcinogenesis and its clinical implications.
    Helicobacter. 2018 Apr 15:e12486. doi: 10.1111/hel.12486.
    PubMed     Abstract available

  260. KIM TJ, Kim ER, Chang DK, Kim YH, et al
    Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenoma-author's reply.
    Helicobacter. 2018 Apr 11:e12484. doi: 10.1111/hel.12484.

  261. VENNEMAN K, Huybrechts I, Gunter MJ, Vandendaele L, et al
    The epidemiology of Helicobacter pylori infection in Europe and the impact of lifestyle on its natural evolution toward stomach cancer after infection: A systematic review.
    Helicobacter. 2018 Apr 10:e12483. doi: 10.1111/hel.12483.
    PubMed     Abstract available

    March 2018
  262. PARK H, Park JJ, Park YM, Baik SJ, et al
    The association between Helicobacter pylori infection and the risk of advanced colorectal neoplasia may differ according to age and cigarette smoking.
    Helicobacter. 2018 Mar 29:e12477. doi: 10.1111/hel.12477.
    PubMed     Abstract available

  263. CREMNITER J, Bodet C, Tougeron D, Dray X, et al
    Th-17 response and antimicrobial peptide expression are uniformly expressed in gastric mucosa of Helicobacter pylori-infected patients independently of their clinical outcomes.
    Helicobacter. 2018 Mar 27:e12479. doi: 10.1111/hel.12479.
    PubMed     Abstract available

  264. MIERNYK KM, Bulkow LR, Gold BD, Bruce MG, et al
    Prevalence of Helicobacter pylori among Alaskans: Factors associated with infection and comparison of urea breath test and anti-Helicobacter pylori IgG antibodies.
    Helicobacter. 2018 Mar 14. doi: 10.1111/hel.12482.
    PubMed     Abstract available

  265. SHU X, Yin G, Liu M, Peng K, et al
    Antibiotics resistance of Helicobacter pylori in children with upper gastrointestinal symptoms in Hangzhou, China.
    Helicobacter. 2018 Mar 12. doi: 10.1111/hel.12481.
    PubMed     Abstract available

  266. KIM JH, Lee SY, Lee SP, Kim JH, et al
    The histologic detection of Helicobacter pylori in seropositive subjects is affected by pathology and secretory ability of the stomach.
    Helicobacter. 2018 Mar 8. doi: 10.1111/hel.12480.
    PubMed     Abstract available

  267. YEN CH, Chiu HF, Huang SY, Lu YY, et al
    Beneficial effect of Burdock complex on asymptomatic Helicobacter pylori-infected subjects: A randomized, double-blind placebo-controlled clinical trial.
    Helicobacter. 2018 Mar 8. doi: 10.1111/hel.12469.
    PubMed     Abstract available

  268. LIU WZ, Xie Y, Lu H, Cheng H, et al
    Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection.
    Helicobacter. 2018 Mar 7. doi: 10.1111/hel.12475.
    PubMed     Abstract available

  269. SUGIZAKI K, Tari A, Kitadai Y, Oda I, et al
    Anti-Helicobacter pylori therapy in localized gastric mucosa-associated lymphoid tissue lymphoma: A prospective, nationwide, multicenter study in Japan.
    Helicobacter. 2018 Mar 4. doi: 10.1111/hel.12474.
    PubMed     Abstract available

  270. OPEKUN AR, Gonzales SA, Al-Saadi MA, Graham DY, et al
    Brief report: Lactobacillus bulgaricus GLB44 (Proviotic() ) plus esomeprazole for Helicobacter pylori eradication: A pilot study.
    Helicobacter. 2018 Mar 4. doi: 10.1111/hel.12476.
    PubMed     Abstract available

  271. LEE YC, Asaka M, Graham DY
    Helicobacter pylori and gastric cancer in Alaskan Natives: Time to stop studyingH. pylori and to eradicate it.
    Helicobacter. 2018 Mar 2. doi: 10.1111/hel.12478.

    February 2018
  272. OHISHI T, Masuda T, Abe H, Hayashi C, et al
    Monotherapy with a novel intervenolin derivative, AS-1934, is an effective treatment for Helicobacter pylori infection.
    Helicobacter. 2018 Feb 28. doi: 10.1111/hel.12470.
    PubMed     Abstract available

  273. TALARICO S, Korson AS, Leverich CK, Park S, et al
    High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR.
    Helicobacter. 2018 Feb 26. doi: 10.1111/hel.12472.
    PubMed     Abstract available

  274. KUO YC, Shih SC, Yu LY, Wu MS, et al
    Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenoma.
    Helicobacter. 2018 Feb 26. doi: 10.1111/hel.12473.

  275. ZHUGE L, Wang Y, Wu S, Zhao RL, et al
    Furazolidone treatment for Helicobacter Pylori infection: A systematic review and meta-analysis.
    Helicobacter. 2018 Feb 26. doi: 10.1111/hel.12468.
    PubMed     Abstract available

  276. SIAVOSHI F, Sahraee M, Ebrahimi H, Sarrafnejad A, et al
    Natural fruits, flowers, honey, and honeybees harbor Helicobacter pylori-positive yeasts.
    Helicobacter. 2018 Feb 19. doi: 10.1111/hel.12471.
    PubMed     Abstract available

  277. WANG YH, Li Z, Wang L, Zhu-Ge LY, et al
    A systematic review and meta-analysis of genotypic methods for detecting antibiotic resistance in Helicobacter pylori.
    Helicobacter. 2018 Feb 6. doi: 10.1111/hel.12467.
    PubMed     Abstract available

    January 2018
  278. CHOE JW, Jung SW, Kim SY, Hyun JJ, et al
    Comparative study of Helicobacter pylori eradication rates of concomitant therapy vs modified quadruple therapy comprising proton-pump inhibitor, bismuth, amoxicillin, and metronidazole in Korea.
    Helicobacter. 2018 Jan 25. doi: 10.1111/hel.12466.
    PubMed     Abstract available

  279. BAE SE, Choi KD, Choe J, Kim SO, et al
    The effect of eradication of Helicobacter pylori on gastric cancer prevention in healthy asymptomatic populations.
    Helicobacter. 2018 Jan 18. doi: 10.1111/hel.12464.
    PubMed     Abstract available

  280. DORE MP, Salis R, Loria MF, Villanacci V, et al
    Helicobacter pylori infection and occurrence of celiac disease in subjects HLA-DQ2/DQ8 positive: A prospective study.
    Helicobacter. 2018 Jan 18. doi: 10.1111/hel.12465.
    PubMed     Abstract available

  281. LEE JH, Choi KD, Jung HY, Baik GH, et al
    Seroprevalence of Helicobacter pylori in Korea: A multicenter, nationwide study conducted in 2015 and 2016.
    Helicobacter. 2018 Jan 18. doi: 10.1111/hel.12463.
    PubMed     Abstract available

  282. BOEHNKE KF, Brewster RK, Sanchez BN, Valdivieso M, et al
    An assessment of drinking water contamination with Helicobacter pylori in Lima, Peru.
    Helicobacter. 2018 Jan 8. doi: 10.1111/hel.12462.
    PubMed     Abstract available

  283. WANG YK, Chiang WC, Kuo FC, Wu MC, et al
    Levels of malondialdehyde in the gastric juice: Its association with Helicobacter pylori infection and stomach diseases.
    Helicobacter. 2018 Jan 5. doi: 10.1111/hel.12460.
    PubMed     Abstract available

    December 2017
  284. SUE S, Ogushi M, Arima I, Kuwashima H, et al
    Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori: A multicenter, prospective, randomized trial.
    Helicobacter. 2017 Dec 21. doi: 10.1111/hel.12456.
    PubMed     Abstract available

  285. CEN L, Pan J, Zhou B, Yu C, et al
    Helicobacter Pylori infection of the gallbladder and the risk of chronic cholecystitis and cholelithiasis: A systematic review and meta-analysis.
    Helicobacter. 2017 Dec 20. doi: 10.1111/hel.12457.
    PubMed     Abstract available

  286. STENT A, Every AL, Chionh YT, Ng GZ, et al
    Superoxide dismutase from Helicobacter pylori suppresses the production of pro-inflammatory cytokines during in vivo infection.
    Helicobacter. 2017 Dec 13. doi: 10.1111/hel.12459.
    PubMed     Abstract available

  287. GONZALEZ-PONS M, Soto-Salgado M, Sevilla J, Marquez-Lespier JM, et al
    Seroprevalence of Helicobacter pylori in Hispanics living in Puerto Rico: A population-based study.
    Helicobacter. 2017 Dec 6. doi: 10.1111/hel.12453.
    PubMed     Abstract available

    November 2017
  288. DOULBERIS M, Kotronis G, Thomann R, Polyzos SA, et al
    Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?
    Helicobacter. 2017 Nov 27. doi: 10.1111/hel.12454.
    PubMed     Abstract available

  289. BEER-DAVIDSON G, Hindiyeh M, Muhsen K
    Detection of Helicobacter pylori in stool samples of young children using real-time polymerase chain reaction.
    Helicobacter. 2017 Nov 27. doi: 10.1111/hel.12450.
    PubMed     Abstract available

  290. MUNOZ-GOMEZ P, Jordan-Castro JA, Abanades-Tercero M, Blanco-Gonzalez JJ, et al
    Macrolide use in the previous years is associated with failure to eradicate Helicobacter pylori with clarithromycin-containing regimens.
    Helicobacter. 2017 Nov 26. doi: 10.1111/hel.12452.
    PubMed     Abstract available

  291. NG QX, Venkatanarayanan N, De Deyn MLZQ, Ho CYX, et al
    A meta-analysis of the association between Helicobacter pylori (H. pylori) infection and hyperemesis gravidarum.
    Helicobacter. 2017 Nov 26. doi: 10.1111/hel.12455.
    PubMed     Abstract available

  292. HAYS C, Burucoa C, Lehours P, Tran CT, et al
    Molecular characterization of Helicobacter pylori resistance to rifamycins.
    Helicobacter. 2017 Nov 23. doi: 10.1111/hel.12451.
    PubMed     Abstract available

  293. KAWAKUBO M, Horiuchi K, Matsumoto T, Nakayama J, et al
    Cholesterol-alpha-glucosyltransferase gene is present in most Helicobacter species including gastric non-Helicobacter pylori helicobacters obtained from Japanese patients.
    Helicobacter. 2017 Nov 7. doi: 10.1111/hel.12449.
    PubMed     Abstract available

  294. FIORINI G, Saracino IM, Zullo A, Gatta L, et al
    Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strains.
    Helicobacter. 2017 Nov 1. doi: 10.1111/hel.12448.
    PubMed     Abstract available

    October 2017
  295. PASTUKH N, Binyamin D, On A, Paritsky M, et al
    GenoType(R) HelicoDR test in comparison with histology and culture for Helicobacter pylori detection and identification of resistance mutations to clarithromycin and fluoroquinolones.
    Helicobacter. 2017 Oct 23. doi: 10.1111/hel.12447.
    PubMed     Abstract available

  296. RAAF N, Amhis W, Saoula H, Abid A, et al
    Prevalence, antibiotic resistance, and MLST typing of Helicobacter pylori in Algiers, Algeria.
    Helicobacter. 2017 Oct 16. doi: 10.1111/hel.12446.
    PubMed     Abstract available

  297. TAKEOKA A, Tayama J, Kobayashi M, Sagara I, et al
    Psychological effects of Helicobacter pylori-associated atrophic gastritis in patients under 50 years: A cross-sectional study.
    Helicobacter. 2017 Oct 16. doi: 10.1111/hel.12445.
    PubMed     Abstract available

  298. ATILGAN CU, Kosekahya P, Yozgat A, Sen E, et al
    Are optic nerve heads of patients with helicobacter pylori infection more susceptible to glaucomatous damage?
    Helicobacter. 2017 Oct 5. doi: 10.1111/hel.12443.
    PubMed     Abstract available

    September 2017
  299. KHADANGI F, Yassi M, Kerachian MA
    Diagnostic accuracy of PCR-based detection tests for Helicobacter Pylori in stool samples: A systematic review and meta-analysis.
    Helicobacter. 2017 Sep 29. doi: 10.1111/hel.12444.
    PubMed     Abstract available

  300. WANGDA S, Richter JM, Kuenzang P, Wangchuk K, et al
    Epidemiology of Helicobacter pylori infection in asymptomatic schoolchildren in Bhutan.
    Helicobacter. 2017 Sep 22. doi: 10.1111/hel.12439.
    PubMed     Abstract available

  301. KIM SY, Lee SW, Choe JW, Jung SW, et al
    Helicobacter pylori eradication rates of concomitant and sequential therapies in Korea.
    Helicobacter. 2017 Sep 21. doi: 10.1111/hel.12441.
    PubMed     Abstract available

  302. MACIAS-GARCIA F, Llovo-Taboada J, Diaz-Lopez M, Baston-Rey I, et al
    High primary antibiotic resistance of Helicobacter Pylori strains isolated from dyspeptic patients: A prevalence cross-sectional study in Spain.
    Helicobacter. 2017 Sep 15. doi: 10.1111/hel.12440.
    PubMed     Abstract available

  303. DONG SQ, Singh TP, Wei X, Yao H, et al
    A Japanese population-based meta-analysis of vonoprazan versus PPI for Helicobacter pylori eradication therapy: Is superiority an illusion?
    Helicobacter. 2017 Sep 8. doi: 10.1111/hel.12438.
    PubMed     Abstract available

  304. KALACH N, Bontems P, Raymond J
    Helicobacter pylori infection in children.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Abstract available

  305. BURUCOA C, Axon A
    Epidemiology of Helicobacter pylori infection.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Abstract available

  306. O'CONNOR A, Lamarque D, Gisbert JP, O'Morain C, et al
    Treatment of Helicobacter pylori infection 2017.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Abstract available

  307. SJOMINA O, Heluwaert F, Moussata D, Leja M, et al
    Helicobacter pylori infection and nonmalignant diseases.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Abstract available

  308. BESSEDE E, Arantes V, Megraud F, Coelho LG, et al
    Diagnosis of Helicobacter pylori infection.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Abstract available

  309. DE KORWIN JD, Ianiro G, Gibiino G, Gasbarrini A, et al
    Helicobacter pylori infection and extragastric diseases in 2017.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Abstract available

  310. THORELL K, Lehours P, Vale FF
    Genomics of Helicobacter pylori.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Abstract available

  311. CAMILO V, Sugiyama T, Touati E
    Pathogenesis of Helicobacter pylori infection.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Abstract available

  312. VENERITO M, Vasapolli R, Rokkas T, Delchier JC, et al
    Helicobacter pylori, gastric cancer and other gastrointestinal malignancies.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Abstract available

    August 2017
  313. GUO L, Yin R, Xu G, Gong X, et al
    Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.
    Helicobacter. 2017 Aug 29. doi: 10.1111/hel.12428.
    PubMed     Abstract available

  314. KWON YH, Kim JY, Kim N, Park JH, et al
    Specific mutations of penicillin-binding protein 1A in 77 clinically acquired amoxicillin-resistant Helicobacter pylori strains in comparison with 77 amoxicillin-susceptible strains.
    Helicobacter. 2017 Aug 25. doi: 10.1111/hel.12437.
    PubMed     Abstract available

  315. MIEHLKE S, Frederking D, Gunther T, Glocker E, et al
    Efficacy of three-in-one capsule bismuth quadruple therapy for Helicobacter pylori eradication in clinical practice in a multinational patient population.
    Helicobacter. 2017 Aug 22. doi: 10.1111/hel.12429.
    PubMed     Abstract available

  316. CHOI SH, Kim DM, Lee J, Yun NR, et al
    Endoscopic characteristics of infection-associated peptic ulcers.
    Helicobacter. 2017 Aug 18. doi: 10.1111/hel.12427.
    PubMed     Abstract available

  317. LIU W, Tan Z, Liu H, Zeng Z, et al
    Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori.
    Helicobacter. 2017 Aug 14. doi: 10.1111/hel.12426.
    PubMed     Abstract available

  318. GINESTET F, Guibourg B, Doucet L, Thereaux J, et al
    Upfront immunohistochemistry improves specificity of Helicobacter pylori diagnosis. A French pathology laboratory point of view.
    Helicobacter. 2017 Aug 11. doi: 10.1111/hel.12424.
    PubMed     Abstract available

  319. TSUDA M, Asaka M, Kato M, Matsushima R, et al
    Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan.
    Helicobacter. 2017 Aug 3. doi: 10.1111/hel.12415.
    PubMed     Abstract available

  320. RODRIGUEZ DE SANTIAGO E, Martin de Argila de Prados C, Marcos Prieto HM, Jorge Turrion MA, et al
    Limited effectiveness with a 10-day bismuth-containing quadruple therapy (Pylera(R) ) in third-line recue treatment for Helicobacter pylori infection. A real-life multicenter study.
    Helicobacter. 2017 Aug 3. doi: 10.1111/hel.12423.
    PubMed     Abstract available

  321. ZHOU X, Su J, Zhu L, Zhang G, et al
    Helicobacter pylori modulates cisplatin sensitivity in gastric cancer by down-regulating miR-141 expression.
    Helicobacter. 2017;22.

    July 2017
  322. FERNANDEZ-DE-LARREA N, Michel A, Romero B, Butt J, et al
    Antibody reactivity against Helicobacter pylori proteins in a sample of the Spanish adult population in 2008-2013.
    Helicobacter. 2017 Jul 24. doi: 10.1111/hel.12401.
    PubMed     Abstract available

    June 2017
  323. BUTENKO T, Jeverica S, Orel R, Homan M, et al
    Antibacterial resistance and the success of tailored triple therapy in Helicobacter pylori strains isolated from Slovenian children.
    Helicobacter. 2017 Jun 27. doi: 10.1111/hel.12400.
    PubMed     Abstract available

  324. ZABALA TORRRES B, Lucero Y, Lagomarcino AJ, Orellana-Manzano A, et al
    Prevalence and dynamics of Helicobacter pylori infection during childhood.
    Helicobacter. 2017 Jun 23. doi: 10.1111/hel.12399.
    PubMed     Abstract available

  325. SHEN X, Yang H, Wu Y, Zhang D, et al
    Association of Helicobacter pylori infection with Parkinson's diseases: A meta-analysis.
    Helicobacter. 2017 Jun 9. doi: 10.1111/hel.12398.
    PubMed     Abstract available

    May 2017
  326. OSAKI T, Mabe K, Zaman C, Yonezawa H, et al
    Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy.
    Helicobacter. 2017 May 22. doi: 10.1111/hel.12396.
    PubMed     Abstract available

  327. SECKA O, Vale FF, Buissonniere A, Thomas JE, et al
    Phylogeographic agreement between prophage and bacterial housekeeping genes in Helicobacter pylori strains from The Gambia.
    Helicobacter. 2017 May 22. doi: 10.1111/hel.12394.

  328. SHEHATA MA, Talaat R, Soliman S, Elmesseri H, et al
    Randomized controlled study of a novel triple nitazoxanide (NTZ)-containing therapeutic regimen versus the traditional regimen for eradication of Helicobacter pylori infection.
    Helicobacter. 2017 May 19. doi: 10.1111/hel.12395.
    PubMed     Abstract available

    April 2017
  329. BOEHNKE KF, Eaton KA, Fontaine C, Brewster R, et al
    Reduced infectivity of waterborne viable but nonculturable Helicobacter pylori strain SS1 in mice.
    Helicobacter. 2017 Apr 24. doi: 10.1111/hel.12391.
    PubMed     Abstract available

  330. SILVA B, Nunes A, Vale FF, Rocha R, et al
    The expression of Helicobacter pylori tfs plasticity zone cluster is regulated by pH and adherence, and its composition is associated with differential gastric IL-8 secretion.
    Helicobacter. 2017 Apr 24. doi: 10.1111/hel.12390.
    PubMed     Abstract available

  331. JUNG YS, Park CH, Park JH, Nam E, et al
    Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta-analysis.
    Helicobacter. 2017 Apr 19. doi: 10.1111/hel.12389.
    PubMed     Abstract available

  332. KOCSMAR E, Szirtes I, Kramer Z, Szijarto A, et al
    Sensitivity of Helicobacter pylori detection by Giemsa staining is poor in comparison with immunohistochemistry and fluorescent in situ hybridization and strongly depends on inflammatory activity.
    Helicobacter. 2017 Apr 12. doi: 10.1111/hel.12387.
    PubMed     Abstract available

  333. ANSARI S, Yamaoka Y
    Survival of Helicobacter pylori in gastric acidic territory.
    Helicobacter. 2017 Apr 12. doi: 10.1111/hel.12386.
    PubMed     Abstract available

  334. LEE AY, Kao CY, Wang YK, Lin SY, et al
    Inactivation of ferric uptake regulator (Fur) attenuates Helicobacter pylori J99 motility by disturbing the flagellar motor switch and autoinducer-2 production.
    Helicobacter. 2017 Apr 12. doi: 10.1111/hel.12388.
    PubMed     Abstract available

  335. AL-SINANI S, Al-Mulaabed SW, Al-Naamani K, Al-Sharji H, et al
    Helicobacter Pylori infection in Omani children.
    Helicobacter. 2017;22.

    March 2017
  336. CHENG HC, Tsai YC, Yang HB, Yeh YC, et al
    The corpus-predominant gastritis index can be an early and reversible marker to identify the gastric cancer risk of Helicobacter pylori-infected nonulcer dyspepsia.
    Helicobacter. 2017 Mar 22. doi: 10.1111/hel.12385.
    PubMed     Abstract available

  337. KOTILEA K, Mekhael J, Salame A, Mahler T, et al
    Eradication rate of Helicobacter Pylori infection is directly influenced by adherence to therapy in children.
    Helicobacter. 2017 Mar 17. doi: 10.1111/hel.12383.
    PubMed     Abstract available

  338. BARTELS LE, Jepsen P, Tottrup A, Vilstrup H, et al
    Helicobacter pylori infection is associated with reduced prevalence of colonic diverticular disease.
    Helicobacter. 2017 Mar 16. doi: 10.1111/hel.12384.
    PubMed     Abstract available

  339. OLEASTRO M, Rocha R, Vale FF
    Population genetic structure of Helicobacter pylori strains from Portuguese-speaking countries.
    Helicobacter. 2017 Mar 8. doi: 10.1111/hel.12382.
    PubMed     Abstract available

    February 2017
  340. CHUAH YY, Wu DC, Chuah SK, Yang JC, et al
    Real-world practice and Expectation of Asia-Pacific physicians and patients in Helicobacter Pylori eradication (REAP-HP Survey).
    Helicobacter. 2017 Feb 28. doi: 10.1111/hel.12380.
    PubMed     Abstract available

  341. ALVAREZ A, Toledo H
    The histone-like protein HU has a role in gene expression during the acid adaptation response in Helicobacter pylori.
    Helicobacter. 2017 Feb 28. doi: 10.1111/hel.12381.
    PubMed     Abstract available

  342. NG GZ, Ke BX, Laskowski A, Thorburn DR, et al
    No evidence of a role for mitochondrial complex I in Helicobacter pylori pathogenesis.
    Helicobacter. 2017 Feb 9. doi: 10.1111/hel.12378.
    PubMed     Abstract available

    January 2017
  343. TURSI A, Di Mario F, Franceschi M, De Bastiani R, et al
    New bismuth-containing quadruple therapy in patients infected with Helicobacter pylori: A first Italian experience in clinical practice.
    Helicobacter. 2017 Jan 26. doi: 10.1111/hel.12371.
    PubMed     Abstract available

  344. KIM TJ, Kim ER, Chang DK, Kim YH, et al
    Helicobacter pylori infection is an independent risk factor of early and advanced colorectal neoplasm.
    Helicobacter. 2017 Jan 26. doi: 10.1111/hel.12377.
    PubMed     Abstract available

  345. TANAKA S, Nagashima H, Uotani T, Graham DY, et al
    Autophagy-related genes in Helicobacter pylori infection.
    Helicobacter. 2017 Jan 23. doi: 10.1111/hel.12376.
    PubMed     Abstract available

  346. ONO S, Kato M, Nakagawa S, Mabe K, et al
    Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin.
    Helicobacter. 2017 Jan 18. doi: 10.1111/hel.12374.
    PubMed     Abstract available

  347. MORAIS S, Costa AR, Ferro A, Lunet N, et al
    Contemporary migration patterns in the prevalence of Helicobacter pylori infection: A systematic review.
    Helicobacter. 2017 Jan 18. doi: 10.1111/hel.12372.
    PubMed     Abstract available

  348. LI L, Ke Y, Yu C, Li G, et al
    Antibiotic resistance of Helicobacter pylori in Chinese children: A multicenter retrospective study over 7 years.
    Helicobacter. 2017 Jan 18. doi: 10.1111/hel.12373.
    PubMed     Abstract available

  349. SHEU BS, Wu MS, Chiu CT, Lo JC, et al
    Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale.
    Helicobacter. 2017 Jan 8. doi: 10.1111/hel.12368.
    PubMed     Abstract available

    December 2016
  350. SONNENBERG A, Dellon ES, Turner KO, Genta RM, et al
    The influence of Helicobacter pylori on the ethnic distribution of esophageal eosinophilia.
    Helicobacter. 2016 Dec 28. doi: 10.1111/hel.12370.
    PubMed     Abstract available

  351. SHAMSDIN SA, Alborzi A, Rasouli M, Ghaderi A, et al
    The importance of TH22 and TC22 cells in the pathogenesis of Helicobacter pylori-associated gastric diseases.
    Helicobacter. 2016 Dec 19. doi: 10.1111/hel.12367.
    PubMed     Abstract available

  352. SUN X, Zhang M, El-Zaatari M, Huffnagle GB, et al
    CCR2 mediates Helicobacter pylori-induced immune tolerance and contributes to mucosal homeostasis.
    Helicobacter. 2016 Dec 8. doi: 10.1111/hel.12366.
    PubMed     Abstract available

    November 2016
  353. FERENC S, Gnus J, Koscielna M, Kinda M, et al
    High antibiotic resistance of Helicobacter pylori and its effect on tailored and empiric eradication of the organism in Lower Silesia, Poland.
    Helicobacter. 2016 Nov 23. doi: 10.1111/hel.12365.
    PubMed     Abstract available

    October 2016
  354. DEN HOLLANDER WJ, Schalekamp-Timmermans S, Holster IL, Jaddoe VW, et al
    Helicobacter pylori colonization and pregnancies complicated by preeclampsia, spontaneous prematurity, and small for gestational age birth.
    Helicobacter. 2016 Oct 27. doi: 10.1111/hel.12364.
    PubMed     Abstract available

  355. NAKAYAMA Y, Lin Y, Hongo M, Hidaka H, et al
    Helicobacter pylori infection and its related factors in junior high school students in Nagano Prefecture, Japan.
    Helicobacter. 2016 Oct 27. doi: 10.1111/hel.12363.
    PubMed     Abstract available

  356. ZHOU L, Zhao F, Hu B, Fang Y, et al
    A Creative Helicobacter pylori Diagnosis Scheme Based on Multiple Genetic Analysis System: Qualification and Quantitation.
    Helicobacter. 2016;21:441.

    September 2016
  357. MIHARA H, Suzuki N, Muhammad JS, Nanjo S, et al
    Transient receptor potential vanilloid 4 (TRPV4) silencing in Helicobacter pylori-infected human gastric epithelium.
    Helicobacter. 2016 Sep 30. doi: 10.1111/hel.12361.
    PubMed     Abstract available

  358. ABDUL RAHIM NR, Benson J, Grocke K, Vather D, et al
    Prevalence of Helicobacter pylori infection in newly arrived refugees attending the Migrant Health Service, South Australia.
    Helicobacter. 2016 Sep 22. doi: 10.1111/hel.12360.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.